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Synopsis 
 
This research work provided the necessary information for planning a definitive trial 
investigating the clinical effectiveness of monofilament non-braided suture materials in 
reducing pregnancy loss rate following cervical cerclage compared to the traditional 
multifilament braided sutures. 
 
The main aim of COTS was to conduct a feasibility / pilot RCT to study a number of aspects 
of how the main trial will be optimally delivered. 
 
COTS provided necessary information to plan and confidently run a definitive trial that will 
be able to determine the clinical and cost effectiveness of the different types of suture 
material. If the current perceived benefit of monofilament sutures is confirmed, this policy 
will be rapidly adopted nationally. In the UK alone this could potentially prevent more than 
300 babies per annum dying as a result of mid-trimester loss, intrauterine infection or 
complications of prematurity. Moreover, reducing the risk of prematurity will reduce neonatal 
unit and hospital stay, the significant morbidity associated with early gestation and the 
associated long-term morbidity. This will have psychosocial benefits and significant cost 
saving for the NHS and the wider community.  
 
  I have conducted a retrospective analysis of a cohort of pregnant women who had 
history indicated or ultrasound indicated cervical cerclage using either Nylon 
(monofilament unbraided) suture or Mersilene (braided) suture at Birmingham 
Women’s Hospital and Addenbrookes Hospital in Cambridge from January 2004 till 
 
 
December 2010. The data collection was later extended to March 2015 and combined 
with retrospective data from King’s College London Professor P Bennet’s group and 
published. Data was collected and analysed within the frames of audit recommended 
by RCOG looking at the pregnancy loss rate at less than 24 weeks of gestation and 
preterm delivery at 24-32 weeks of gestation in each unit.  
 
 I have conducted a national survey of Consultant Obstetricians and Gynaecologists 
based in the UK to identify the type of suture materials commonly used for cerclage. 
I have reviewed current practice with regards to criteria used for recommending 
cerclage; explored their willingness to participate in pilot/feasibility study and ensured 
the relevance of selected outcomes for the RCT.  
 
 I have performed a systematic review of the published literature on Medline, CINAHL 
and Embase. My objective was to evaluate rate of pregnancy loss associated with 
the type of suture material used for history indicated and ultrasound indicated cervical 
cerclage comparing braided (multifilament) versus non-braided (monofilament) 
sutures. 
 
 After this preliminary work I have developed trial documents. I have tested the study 
protocol that has been designed with the full scale trial in mind. I have developed and 
established an active COTS-PPI group that had an active role at the outset of the 
feasibility project and participated throughout the definitive trial. I have gained insight 
into any professional or organisational barriers that were obstacles to a full study. I 
have tested recruitment and randomisation procedures. I have calculated an accurate 
 
 
estimate of NHS and service costs involved as well as the level of resource required 
to ensure successful delivery of the full trial. I have examined general data collection, 
cleaning, input and analysis procedures, and established the benefits of the one type 
of suture over the other in cases of elective cervical cerclage.  
 
The size of the pilot study did not allow reliable assessment of the effect of the different 
suture materials on clinical outcomes.  However, we did collect information from 
collaborating units on the numbers of women requiring cervical cerclage and eligible for the 
study and those women’s birth outcomes.  This gave a larger prospective sample on which 
to base the power calculation. COTS enabled me to precisely estimate (a) the recruitment 
rate, (b) attrition rate, and (c) rate of occurrence of the primary outcome in both groups. 
During the pilot study, accurate assessment of the numbers of women eligible, approached 
and recruited was made. 
 
Based on the findings of COTS trial, funding was sought from the NIHR HTA programme, and we 
were successful in being awarded £1.2 million (co-applicant) to conduct a multi-centre randomised 
controlled trial (RCT): The C-STICH trial Cerclage Suture Type for an Insufficient Cervix and its effect 
on Health outcomes Trial: a randomised controlled Trial of monofilament versus braided sutures for 
insufficient cervix. 
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1.1 Preterm birth 
 
1.1.1 Definition and incidence 
 
Preterm birth is defined as birth before thirty-seven completed weeks of pregnancy (less 
than 259 days after the last menstrual period). It is subdivided according to gestational age 
into following categories: extremely preterm (<28 wk), very preterm (28–31 wk) and late 
preterm (32–36 wk). Preterm birth remains one of the main challenges for modern obstetrics 
and maternity care worldwide and is World Health Organisation priority1. Despite recent 
advances in perinatal care, premature delivery remains the main cause of perinatal mortality 
and morbidity in developed countries. Globally with the incidence of 28% PTB constitutes 
the main direct cause of neonatal death worldwide, surpassing severe infections (26%) and 
asphyxia (23%)2. PTB remains the second most common cause of death even in children 
up to 5 years of age. The current incidence of preterm birth in high income countries is 9 % 
and it is still rising in some countries. According to the data from the report, by Liu L et al3 
1.1 million babies die each year in the world as a result of prematurity and many of those 
who survive remain disabled. The World Health Association (WHO) undertook a review of 
preterm birth incidence rate worldwide with all UN member states participating. The review 
estimated that fifteen million babies were born prematurely in 2010 with 5% born severely 
premature (defined as under 28 weeks of gestation). In UK approximately 60,000 babies are 
born prematurely every year with around 10,000 babies being born at a gestation of <32 
weeks. Tragically, approximately 1,500 of them die. Gestational age at delivery is inversely 
proportional to mortality, so that the earlier the gestation at delivery the higher the mortality 
and requirement for intensive care admission. There is also a greater risk of disability and 
the need for additional support in those that survive with life-long disabilities. Recently it has 
been acknowledged that the gestational age rather than birth weight predominantly 
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determines the outcome- survival and long-term consequences of birth4. For example, 
currently babies born at 32 weeks of gestation have perinatal mortality of 2% but it reaches 
90% for those born at 23 weeks5. In circumstances where the gestational age where the 
gestational age is not known birth weight can be as used as a surrogate for example: 
<1,000 g for extremely preterm birth (<28 wk) and 1,000 to <1,500 g for very preterm birth 
(28–31 wk). 
1.1.2 Neonatal complications 
 
Children born prematurely quite often develop additional complications/morbidities for 
example underdeveloped lungs, leading to respiratory distress syndrome, which requires 
ventilation support and admission to neonatal unit, bronchopulmonary dysplasia, 
intraventricular haemorrhage, retrolental fibroplasias and retinopathy of prematurity (ROP). 
They also may have developmental problems, learning difficulties and behavioural problems 
in later life.  Further sequelae are that premature children are more prone to development 
of chronic lung and heart conditions, attention deficit disorder, asthma, diabetes and 
hypertension in later life. Diabetes and hypertension in mothers are associated with 
increased risk of preterm birth, so prenatal and antenatal care for women affected by those 
conditions is of paramount importance as preterm babies themselves have a significant 
chance of developing chronic conditions such as hypertension and diabetes in later life 
“creating an intergenerational cycle of risk”6, meaning that events in one generation may 
have far reaching consequences into subsequent generations. 
1.1.3 Financial implications 
 
There is a correlation between gestation at delivery and likelihood of admission to a neonatal 
unit and/or a need for special support which can last for many weeks and sometimes 
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months. It is estimated that 10% of healthcare resources in developed countries is spent on 
dealing with these consequences. In the UK the cost of preterm birth and its complications 
imposes a significant health care cost burden on NHS where the annual cost to the NHS for 
neonatal care is approximately £2.9billion7. 
1.1.4 Emotional implications 
 
Apart from a colossal economic impact on health care resources, preterm birth and its 
consequences has a potential to have significant negative impact of family, parents and 
bonding8. Parental stress can be very high when children are born prematurely.  A recent 
meta-analysis confirmed that child-related stress is evident more in parents of preterm 
babies when compared to with full term ones9. Deater-Deckard K defined parental stress as 
“a mismatch between perceived resources, expectations and actual caregiving demands”10. 
There is some evidence that the levels of this stress has decreased over the years as a 
result of advances in health care systems and its implications on the outcome of children 
born prematurely9. The Parenting Stress Index-Full Form PSI-FF was developed to grade 
such stress. A premature birth may also influence parental attachment bonds, which are 
considered an important part of parental behavior which leads to the development of 
caregiving in the future. This quality is significantly diminished in parents of preterm babies. 
In order to enhance the ability of a preterm born child’s parents to cope with stress, several 
interventions have been developed. The fundamental principles of any intervention are 
psychological support, parent education and certain developmental therapeutic programs 
for children11. According to the recent RCT the early intervention, for example 
implementation of Mother-Infant Transaction Program (MITP), decreases stress among 
parents of prematurely born children and improves bonds between parents12. 
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1.1.5 Causes of preterm birth 
 
 (Chang HH et al) recently looked at the data from thirty-nine countries with very high human 
development index (VHHDI) in order to understand trends in preterm birth, its causes and 
evidence-based intervention to reduce its incidence13. USA remained one of the countries 
with the highest preterm birth rate with non-medically induced labour, assisted reproduction 
and increased rate of caesarean section being significant factors. In order to decrease the 
incidence of preterm birth several interventions could be implemented pre-conceptually, 
throughout the pregnancy and labour. These interventions could potentially lead to a relative 
5% reduction in preterm birth rate (from 9.59% to 9.07%) in the thirty-nine countries with the 
VHHDI. The ‘Born Too Soon Report’ published in 2012 sets the goal of 50% decrease in a 
rate of preterm birth related mortality by year 2025. Five interventions were identified in this 
report: 
1. Reduction in elective C-sections and inductions of labor without an absolute 
indication 
2. Reduction in multiple embryo transfers during fertility treatment 
3. Smoking cessation programmes for pregnant women 
4. Provision of high- risk pregnant women with progesterone supplementation 
5. Performing cervical cerclage procedure on women with short cervixes  
These interventions were estimated to affect a reduction in 58 000 preterm births in the USA 
and save three million US dollars annually13.  
The risk of preterm birth is also affected by pre-conception advice, medical and surgical 
interventions. Pre-conception identification of risk factors and early counselling gives a 
chance for the implementation of behavioural changes such as smoking cessation and 
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optimisation of chronic medical conditions such as diabetes and hypertension. It is always 
important to consider prolongation of only healthy pregnancy and assess influence on 
perinatal mortality/morbidity5. This is because in some cases, preterm birth is a tool for 
nature to stop the pregnancy as its prolongation may harm the fetus staying in an adverse 
intrauterine environment. Prolongation of such pregnancies may cause harm to the fetus 
and lead to neonatal mortality and morbidity rather than benefit.  
There are preconception surgical interventions such as correcting structural abnormalities 
that can reduce the risk of preterm birth. Such procedures are aimed at normalising uterine 
anatomy where it is deficient, but evidence is limited. Other examples, such as pre-
conceptional placement of abdominal cerclage whether laparoscopically or 
transabdominally have been tried. Again there is no reliable data. The MAVRIC (Multicentre 
randomized trial of high versus low versus abdominal cerclage in women with a previous 
failed stitch) at the time of writing this thesis trial is still ongoing but they have problems with 
recruitment. Nevertheless, vaginal cervical cerclage is included into interventions aimed to 
reduce rates of preterm birth specified in the “Born Too Soon Report” and occupies third 
place after smoking reduction and decreasing multiple embryo transfers during assisted 
reproductive technologies. Cervical cerclage is currently offered to women with a history of 
SPTL or MTL between 16+0 and 34+0 weeks of a previous pregnancy and in whom a 
transvaginal ultrasound scan has been carried out between 16+0 and 24+0 weeks of 
pregnancy that reveals a cervical length of less than 25mm14. Cervix may shorten and dilate 
afterwards due to cervical insufficiency or incompetence. The next section describes 
anatomy, histology and physiology of cervix to explain the concept of cervical incompetence. 
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1.1 Cervix 
 
1.2.1 Anatomy 
 
The cervix represents the lower inferior third of the non-pregnant normal sized uterus 15. In 
adult non-pregnant females, the cervix is cylindrical in shape 2.5-3.0 cm long and 2-2.5 cm 
in diameter. After pregnancy and childbirth it becomes more barrel shaped 16. The ratio of 
the uterine body to cervix changes throughout life. The body to cervix ratio is 2:1 in adult 
non-pregnant females, the same as at the birth of a female fetus when the uterus is quite 
large and is mainly an abdominal organ because of the intrauterine influence of maternal 
hormones. In childhood the cervix is the same length as the body so the ratio is 1:1. After 
the menopause when a uterine body atrophies in size significantly the same proportion with 
the cervix is achieved.  
The junction between the cervix and the main body of the uterus is a zone called the isthmus 
of the uterus, which is approximately 1 cm long. The cervix itself is divided into the 
supravaginal part, which lies between the isthmus and the vagina and the vaginal portion 
below, which is situated at the top of the vagina. The supravaginal portion in the abdomen 
lies between the bladder and the rectum. It is separated from the bladder anteriorly by 
connective tissue15. There is a space between the supravaginal portion of the cervix and the 
rectum called the Pouch of Douglas or recto-uterine pouch. 
The cervix contains a central canal, which connects the uterine cavity to the vagina. The 
canal is fusiform in shape. It extends from the narrowed part inside the isthmus, (the 
anatomical internal os), down through the supravaginal part and vaginal part of the cervix 
into the vagina through the external os15. The external os is different in shape in parous and 
nulliparous women. In parous women the external os looks like a transverse slit, which 
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divides the cervix into anterior and posterior lips. In nulliparous women the external os is 
circular. The cervical canal, together with the uterine cavity and the vagina, forms a birth 
canal through which a fetus passes down during labour. 
 
Figure 1. Cervix in nulliparous and parous women 
 
The uterus and ovaries are supported by several ligaments. The two main ligaments 
attached to the cervix are called the uterosacral and cardinal ligaments. The cardinal 
ligaments, which are also called transverse cervical ligaments, extend from the supravaginal 
part of the cervix to the lateral pelvic side wall. The ureters run in the transition between the 
cardinal and broad ligaments inferior to the uterine arteries, 2 cm lateral to the supravaginal 
part of the cervix. The uterosacral ligaments extend from the superior posterior aspect of the 
cervix to the middle of the sacrum. Their division and suturing during hysterectomy plays an 
important role in the prevention of subsequent vault prolapse 17.  
 
Figure 2. Ligament support to the cervix 
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The blood supply to the cervix is derived from branches of the uterine artery. The uterine 
veins drain the blood from the cervix as well as the uterus and runs within the broad ligament, 
forming a venous plexus on each side of the cervix. The veins run parallel to the arteries. 
The nerves to the cervix derive from the 
uterovaginal nerve plexus. This plexus is 
situated at the junction of the base of the broad 
ligament and the superior part of the transverse 
cervical ligament. It represents one of the pelvic 
nerve plexuses derived from the hypogastric 
plexus. It contains sympathetic, parasympathetic and afferent visceral fibres. Sympathetic 
fibres originate from the inferior thoracic spinal cord segments, they pass through lumbar 
splanchnic nerves and intermesenteric-hypogastric-pelvic plexuses. The parasympathetic 
nerves come from the S2-S4 spinal cord segments and go through the pelvic splachnic 
nerves to the inferior hypogastric-uterovaginal plexus. The visceral afferent innervation is 
divided into superior and inferior components. The inferior one or subperitoneal passes 
impulses from the subperitonel part of the cervix and vagina. The afferent fibres go parallel 
to parasympathetic fibres through uterovaginal and inferior hypogastric plexuses, pelvic 
splanchnic nerves. Those nerves reach spinal sensory ganglia of S2-S415. 
Lymphatic vessels run alongside the blood vessels that supply the uterus and along 
ligaments supporting it. Lymphatic vessels from the cervix run along uterine blood vessels, 
within the cardinal ligaments to internal iliac lymph nodes. They also run alongside 
uterosacral ligaments to the sacral lymph nodes. 
 
Figure 3. Blood supply to the cervix 
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1.2.2 Histology 
 
The cervix varies significantly histologically from the rest of the uterus. The non-pregnant 
cervix is a fibrous structure as opposed to the uterus, which is comprised mainly of smooth 
muscle- myometrium. It is mainly composed of collagen with only a small portion of smooth 
muscle and elastin15. Smooth muscle fibres are embedded into collagen. The proportion of 
muscle to collagen changes through a woman’s life and is affected by parity. 
The vaginal part of the cervix is called ectocervix. It is covered with non-keratinised stratified 
squamous epithelium which continues into the vagina. It is rich in glycogen in females of 
reproductive age and undergoes cyclical changes under the influence of female sex 
hormones. The concentration of glycogen in the cells is less before the menarche and after 
the menopause when the epithelium is much thinner and has fewer layers18. The lining of 
the cervical canal is called the endocervix. It consists of a single layer of columnar mucus-
secreting epithelium- endocervical epithelium18. The 3-dimensional studies indicate that 
there are numerous invaginations of the mucus-secreting epithelium extending into cervical 
stroma18. This arrangement greatly increases the surface for mucus production. 
The border or junction between the squamous epithelium of the ectocervix and the mucous 
secreting columnar epithelium of the endocervix is called the squamocolumnar junction 
(SCJ), which usually lies close to the external os. Under the influence of sex hormones, 
principally oestrogen, at puberty the cells of the columnar epithelium proliferate resulting in 
the SCJ moving the endocervical cells into the vagina, forming an ectropion. Concurrently 
during puberty the pH of the vagina changes and becomes acidic (pH 3)18. The exposure of 
the sensitive columnar epithelium of the ectropion to the acidic environment induces 
squamous metaplasia and creates a transformation zone where the ectocervical columnar 
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epithelium change towards squamous epithelium18. The transformation zone is composed 
of new cells of pseudosquamous epithelium.  
Constant changes in the epithelium may 
sometimes lead to the formation of abnormal cells 
and intraepithelial neoplasia18. When the 
endocervical mucous glands get obliterated or 
blocked then the mucin which they produce cannot 
be secreted into the vagina. It accumulates within 
the glands and presents as flat surfaced lesions on 
the cervix called Nabothian follicles or cysts. Under normal circumstances cervical mucous 
produced by endocervical glands is excreted directly into the endocervical canal and 
thereafter into the vagina. Cervical mucus inside the cervical canal undergoes different 
changes under the influence of progesterone through the menstrual cycle. This mucous 
plays an important part in the process of fertilisation and early pregnancy. The consistency 
of the mucous changes through the cycle: 1) at ovulation mucous is very watery which helps 
for the passage of sperm to the uterine cavity.  2) luteal phase – the  mucous is very thick 
and hinders the passage of sperm16. The excretion of the mucous into the vagina is 
facilitated by a small number of ciliated columnar epithelial cells placed among mucus-
secreting endocervical cells18. This passage of mucus into the vagina contributes to vaginal 
lubrication during intercourse. 
During pregnancy the cervix becomes very rigid16, in order to keep the pregnancy inside the 
uterus, but just before delivery the process of cervical effacement takes place during which 
connective tissue in the cervix undergoes significant changes. The concentration of 
hyaluronic acid in the glycosaminoglycan matrix between the collagen fibres increases 
Figure 4. Squamocolumnar junction 
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significantly. It attracts water and as a result, separates collagen fibres from cervical stroma 
and makes the cervix very soft. Usually collagen and elastin fibres are held together by 
dermatan sulphate bridges. During pregnancy concentration of this compound decreases 
significantly and, as a result, those bridges are weakened  which leads to separation of the 
fibres and further softening of the cervix18. The collagen fibres themselves (type I and type 
II) separate from each other and become short. They also lose their parallel alignment and  
become more haphazard, as a result the cervix softens and - loses its resistance18. If this 
process happens earlier in pregnancy pregnant women may suffer a miscarriage or 
premature labour.  
There are certain changes within the endocervical canal during pregnancy which are 
especially important in the context of this research work. As previously mentioned, the 
endocervical canal contains mucus which changes its consistency throughout the menstrual 
cycle. Mucin inside this mucous acts as an antibacterial substance and prevents the spread 
of bacteria from the vagina into uterine cavity18. At the beginning of pregnancy, the mucous 
inside the canal becomes very thick and forms a mucous plug which remains there until the 
end of the third trimester preventing ascending infection. The challenge is to identify and/or 
to modify the trigger to this process to prevent or delay preterm labour/second trimester 
miscarriage. Whether changes to the cervix lead to the mucus plug being lost and the 
consecutive delivery of the fetus prematurely; or changes in the mucous plug which loses 
its antibacterial qualities, followed by infection which leads to premature birth/miscarriage 
has yet to be fully understood. 
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1.3 Cervical incompetence 
 
Cervical incompetence or insufficiency can be defined as the inability of the uterus to keep 
pregnancy until full term due to a structural or functional problem19. It occurs in 1% of all 
pregnancies and has a recurrence rate of almost 30%19. 
As such approximately 2,000,000 cerclage procedures are performed worldwide annually. 
The majority of those procedures are planned and performed vaginally. Based on our 
survey, 0.5% of pregnant women booked in surveyed units had elective or ultrasound 
indicated cerclage. As a result, approximately 6700 pregnant women are diagnosed with an 
insufficient cervix in the UK each year. So far there is no evidence to support or completely 
reject the use of cervical cerclage. Several RCTs combined in meta-analysis failed to 
demonstrate any evidence to support the use of cerclage20, 21. The recent Cochrane review 
concluded that the procedure reduces the incidence of early delivery in patients at risk of 
recurrent preterm birth but has no statistically significant impact on perinatal mortality or 
morbidity22. 
First time cervical insufficiency or cervical incompetence was mentioned in literature as far 
back as 1658 by Riverius23. He described it as a condition when “the orifice of the womb 
[being] so slack that it cannot rightly contract itself to keep in the seed”. Three centuries 
later, the fathers of cervical cerclage Dr Shirodkar and Dr McDonald described the condition 
as a history of painless cervical dilatation which led to second trimester miscarriage or 
preterm birth in the absence of any other causative factors24. The diagnosis of cervical 
insufficiency has evolved over time. It is quite often made retrospectively once all other 
causes for MTL and preterm birth are excluded. Today diagnosis is made based on cervical 
length measurements that are determined by transvaginal ultrasound scan. The predictive 
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value of those measurements depends on women’s risk status. Irrespective of the women’s 
status the shorter the length of the cervix the higher is the risk. But in low risk women with 
cervical length less than 25 mm the risk of preterm birth remains half of the risk of preterm 
birth in women who are identified as high risk group25. 
 Vaginal ultrasound assessment of the cervix is offered to women with history of previous 
preterm births or MTLs before 24 weeks gestation the current pregnancy.  
Term incompetence is deemed to have a connotation with failure for patients and has now 
become largely obsolete. 
1.3.1 Causes 
 
Some authors have attempted to classify cervical insufficiency depending on possible 
causative factors26. Acquired incompetence may be due to previous obstetrical or 
gynaecological procedures that distort cervical anatomy or cause trauma to the cervix. 
Rarely cervical weakness can be due to congenital causes leading again to anatomical or 
sometimes histological defect. Cervical anatomy can also be distorted by the presence of 
intramural pathology such as low-lying myomas or fibromas. 
 The most important anatomical part of the cervix essential for normal cervical functioning is 
the internal os. Both ultrasound and MRI imaging studies prove and confirm that cervical 
shortening begins at internal os where cervix starts to dilate leading to funnelling27 of the 
cervix. A second, not so well reported, method of cervical assessment is elastogarphy. It 
provides information about cervical consistency especially internal os. It presents the ability 
of tissue to deform under pressure. Obviously the softer the tissue, the easier it changes its 
shape. There are different types of elastography: firstly, static when tissue displacement in 
response to manual compression or physiological movements of vessels is measured, or 
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dynamic, when the speed of shear wave propagation is determined. Elastography provides 
information on the internal os stiffness; this parameter, impossible for manual assessment, 
was shown to correlate with pregnancy outcome and is a strong predictor of preterm 
delivery28. 
The stiffness is determined by the means of strain elastography, using colour scale. There 
are few studies that demonstrated an association between elasticity of internal os and the 
risk of preterm birth. Women with soft internal os (yellow or red colour on scale) on 
assessment by elastography were identified of being at higher risk of preterm birth29, 30. 
One of the main recognised iatrogenic causes of cervical insufficiency is previous excisional 
treatment to the cervix (cone biopsy or loop electrical excision of the transformation zone 
(LLETZ) procedure) for cervical intraepithelial neoplasia. Excision of the external part of the 
cervix makes the cervix shorter and puts women at  risk of preterm birth (PTB)31. The link is 
stronger with more aggressive treatment, such as knife cone and with bigger volume of 
tissue removed during the procedure. Expressly the correlation between PTB and cone 
biopsy is more pronounced when the length of cervix excised is more than 20 mm. Quite 
interesting that there is also some evidence from a cohort of women with untreated CIN that 
there remains a high rate of preterm birth. This suggests that presence of CIN can lead to 
certain changes in the cervix that subsequently lead to preterm birth even without the 
treatment32. The mechanism is still not fully understood. One hypothesis suggests that 
immunological or biochemical changes in cervix leading to altered process of parturition33, 
However it remains more likely that it is the anatomical destruction of cervical tissue which 
is critical to the risk of PTL34. 
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A second factor is the impact of HPV infection and preterm birth. Zhuang et al 
35demonstrated that rate of preterm birth increased in cohort of women with high risk HPV. 
HPV infection in itself does not cause chorioamnionitis in the way seen in most bacterial 
infections, inferring that it leads to preterm delivery via a different route. 
Biochemical changes affecting cervical extracellular matrix (ECM) play a key role in 
adequate mechanical function of the cervix36. The ECM is mainly composed of Type I and 
III collagen, which play a major role in mechanical support for the cervix. As mentioned 
earlier, in this chapter there are also a significant number of proteoglycans in cervix, which 
are important for organisation of collagen fibres. Change in the ECM composition leads to 
cervical shortening and softening which in turn leads to preterm birth. Additional invasion of 
leucocytes and proteolytic enzymes lead to cervical remodelling37. Again the exact 
mechanism remains unknown. It is also reported that the levels of inflammatory cytokines 
such as IL-6, MMP- are increased 8 in women with short cervix. 
1.3.2 Diagnosis 
 
There are no objective investigations or tests that can be performed before pregnancy to 
predict or diagnose subsequent cervical insufficiency. Diagnosis historically has almost 
always been clinical and retrospective depending on history and exclusion of other causes 
of the preterm birth. Hysterosalpingography and use of cervical dilators have been used in 
the past as diagnostic procedures prior to pregnancy but are no longer38used. Cervical 
weakness affects 1% of pregnancies hence, it occurs in approximately 2,000,000 
pregnancies globally per annum39. If a woman had a history of second trimester 
miscarriage(s) or early preterm birth which was accompanied by spontaneous rupture of 
membranes or painless cervical dilatation prior to it with no other cause known, then 
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diagnosis of cervical insufficiency is made. Later in pregnancy a speculum examination can 
be performed to confirm the presence of cervical dilation and fetal membranes in the vagina, 
in which case emergency cerclage can be offered. Since the mid 1990s, transvaginal scan 
(TVS) has increasingly been used to predict the condition based on the scan of cervical 
shortening detected between 14 and 24 weeks of gestation. 
 The advantage of ultrasonographic assessment of the cervix that it is more accurate than 
clinical examination for prediction of PTB. It is not associated with any complications and is 
acceptable by 99% of patients only 2 % reporting discomfort/pain40. It can be done 
transvaginally, transabdominally and through transperineal and translabial approach. It has 
been proven in several studies that sonographically short cervix in midtrimester is 
associated with an increased risk of spontaneous preterm birth in singleton and multiple 
pregnancies irrespective of history of PTB in the past41. Romero et al concluded that the CL 
was sensitive with the cervical length being inversely correlated with the risk of spontaneous 
PTB. However, 75% of women with short cervices do not deliver preterm and therefore it 
was not specific. So the accuracy of cervical length measurement as a predicting tool for 
PTB is only valid in a high risk population42. Other authors looked into correlation between 
shortened cervical length and timing of preterm birth43. They have noted that women with a 
shortened cervical length were more likely to deliver within 4 weeks of their cervical   length 
evaluation than women with longer cervical lengths. Currently transvaginal ultrasound 
examination of the cervix is widely recommended to identify women at high risk of preterm 
delivery. Use of cervical length measurements in low risk population is still quite debatable44. 
The sensitivity of CL measurement in this cohort is about 30-40% as may be PTB in those 
women is not related to the abnormal CL. The 2013 Cochrane review for Cervical 
Assessment by Ultrasound for Preventing Preterm Delivery concluded that CL measurement 
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by TVS is one of the best predictors of PTB in all populations but there is insufficient 
evidence to recommend routine screening of asymptomatic or symptomatic pregnant 
women with TVS without any intervention45. 
Currently a cervical length ‘cut off’ of 25 mm (10 th centile) has been chosen in clinical 
practice or sometimes 15 mm (the second percentile). The cervix measuring less than 25 
mm is called short 42and may be indicative of preterm birth46. The normal cervical length is 
between 15 -50 mm. Timing of a scan and relation to gestational age is important and 
detection of short CL is directly linked to probability of PTB. For example, CL at of 20 mm at 
16 weeks is associated with higher incidence of PTB than the same CL detected first at 20 
or 24 weeks47. Measurements before 14 weeks of gestation are not very helpful as women 
who will deliver extremely preterm usually have CL 25 mm in the first trimester.  
Cervical insufficiency cannot be considered a simple dichotomous diagnosis, as it is a risk 
which is influenced by several factors such as the anatomy of the cervix and other factors 
leading to the process of cervical premature dilatation48. 
 
1.3.3 Treatment 
 
Cervical cerclage, vaginal and intramuscular progesterone, a cervical pessary, or a 
combination of cervical pessary and vaginal progesterone have all been tried as treatments 
for cervical insufficiency. 
Cervical pessary showed promise in a series of non-randomised studies. These were 
followed by a Cochrane49 review, which concluded that the evidence was not robust or 
statistically significant and suggested the need for a full randomised control trial. Two large 
randomised trials have subsequently been published with contradicting evidence50, 51.  
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Both trials aimed to lower the rate of spontaneous birth before 34 weeks of gestation in 
women with singleton pregnancies and short cervix on a transvaginal scan compared with 
expectant management. A silicone pessary was placed around the cervix to support it and 
reduce pressure from the pregnancy on the cervical canal. Initial data from the PECEP (The 
PEsario Cervical para Evitar Prematuridad) trial had 192 women who had a short cervix on 
an ultrasound scan had a cervical pessary inserted and 193 had expectant management. 
The spontaneous birth rate was significantly lower in the pessary group (6% versus 27%, 
odds ratio 0.18, 95% CI 0.08-0.37; p<0.0001). The rate of the preterm birth before 28 weeks 
and 37 weeks of gestation was also reduced and gave hope for this simple method of 
prevention of preterm birth50. However, the latest trial by Nicolaides and his group has shown 
that there was no significant difference in the rate of spontaneous birth before 34 weeks of 
gestation between pessary and control group. (12.0% and 10.8%, respectively; odds ratio 
in the pessary group, 1.12; 95% confidence interval, 0.75–1.69; P = 0.57). Importantly there 
was also no difference in neonatal outcomes51.  
Forty-five percent of participants in the later trial had a CL < 15 mm on TVS were also treated 
with vaginal progesterone. The PECEP trial didn’t report use of progesterone. Goya et al 
also reported substantially higher rate of PTB among controls than Nicolaides et al, which 
remained unexplained. Patients enrolled into Nicolaides trial were at least as likely as those 
in the PECEP trial to have major risk factors for preterm delivery, including previous PTB 
and very short cervix. The potential reason for the lack of demonstrable effect of the pessary 
is that any reduction in PTB may have been achieved by progesterone and so that there is 
no added benefit of pessary. 
The second method of preterm birth/second trimester miscarriage prevention is use of 
progesterone, which promotes myometrial quiescence and inhibits cervical ripening by down 
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regulating the production of cytokines. The premature cervical shortening is proposed to 
occur because of progesterone blockade which leads to loss of mucosal plug in cervical 
canal allowing bacteria to set up an inflammatory process around the fetal membranes. 
Progesterone use has been evaluated in different studies. The most common forms to be 
used an intramuscular 17-hydroxy-progesterone-caproate and intravaginal progesterone. 
There is evidence that synthetic and natural progestogens are not equivalent in their 
efficacy, indications and safety profile. Intramuscular and intravaginal progesterone have 
been used successfully in different patient populations52. For example, in women with 
previous preterm birth or second trimester miscarriage and current singleton pregnancy; 
women with short cervical length on TVS; multiple gestation and preterm birth44, 47, 53-58. 
Evidence supporting progestogen has emerged from two big RCTs. Fonseca et al reported 
a 44% of PTB before 34 weeks of gestation in 250 women with CL<15 mm at 20-25 weeks 
of gestation which was significant [RR 0.56; confidence interval (CI),0.36-0.86]. These data 
were subsequently supported by Hassan et al where the benefit of vaginal progesterone in 
458 women with CL of 10-20 mm at 19-23 weeks of gestation in reducing of preterm birth 
before 33 weeks of gestation was confirmed (RR, 0.55; 95% CI,0.33-0.92)  
 The individual patient data meta-analysis performed in 2012 confirmed that administration 
of vaginal progesterone in asymptomatic women with CL < 25 mm significantly reduced risk 
of PTB occurring at 28 weeks to <35weeks, as well as neonatal mortality, incidence of RDS 
and admission to NNU. Since that its use has been widely used, especially in USA, in 
patients with singleton gestation and short cervix at mid-trimester scan. Some authors 
claimed that the significant reduction in the rate of PTB in USA was due to implemented 
recommendation to use progestogen59. The most recent evidence regarding the use of 
progesterone comes from the largest RCT, the OPPTIMUM trial, which tested vaginal 
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progesterone in 1228 women at risk of preterm birth. This study failed to find any evidence 
to support the use of progesterone in the entire population or in the subgroup of women with 
a CL < 25 mm. One of the criticisms of this trial was that, compliance with medication in the 
trial was only 69%60 but this actually represents better compliance than usually seen in 
normal clinical practice61. A sub analysis looking at route of administration also showed no 
difference in outcomes.62 OPPTIMUM was heavily criticised for lacking subgroup analysis 
as it can lead to minimising bias and identifying those groups of patients, if any, which may 
benefit from progesterone administration. Despite the trial showing no difference in overall 
reduction of PTB, there was a reduction in the occurrence of unwanted neonatal outcomes 
after the administration of progesterone (neonatal death, unadjusted OR 0·17, 95% CI 0·06–
0·49; brain injury on ultrasound 0·50, 0·31–0·84). Disappointingly though these differences 
failed to show any identifiable improvement in child development when assessed at 2 years 
of age (cognitive score, progesterone group vs placebo group, 97·3 [SD 17·9] vs 97·7 [17·5]; 
difference in means −0·48, 95% CI −2·77 to 1·81). 
 Despite these results, some researchers continue to search for evidence supporting those 
methods of PTB prevention with in a single setting, randomising patients to pessary, 
progesterone or cerclage arms63. 
1.4 Cervical cerclage 
 
1.4.1 Indications 
 
Cervical cerclage has been offered to treat cervical insufficiency for over 60 years. One of 
the reasons for its continuous use is the lack of reliable evidence to support an alternative. 
Nevertheless, vaginal cervical cerclage is included in the interventions aimed to reduce rates 
of preterm birth specified in the “Born Too soon report” and occupies third place after 
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smoking reduction and decreasing multiple embryo transfers during assisted reproductive 
technologies. 
The placement of suture is currently only considered for singleton pregnancies and is not 
recommended in twin/multiple pregnancies64. Women who present with history of 
midtrimester loss or previous preterm birth need to have a detailed history taken. Sometimes 
preterm birth can be due to placental abruption, iatrogenic or from multiple gestation so 
those cases have to be excluded from indications for cerclage. 
Currently the UK cerclage practice is based on recommendations from NICE guideline on 
preterm birth14. This has three main indications for cerclage insertion: elective based history, 
proactive based on ultrasound criteria; and emergency/rescue cerclage. In US rescue 
cerclage is called physical-examination indicated cerclage.  
Evidence for history-indicated cerclage mainly derives from a large MRC multicentre study65 
which recruited 1292 women who were deemed to be at high risk of cervical insufficiency 
and randomised them to cerclage  (647 women) versus no intervention (645 women). The 
MRC trial was an equipoise trial. It has been criticised for only recruiting women with 
uncertain diagnosis of cervical insufficiency and in this way diluting the results, as they have 
excluded those at high risk. The inclusion criteria was based on their obstetricians 
uncertainty as to whether to recommend cervical cerclage as intervention. Most women had 
a history of early delivery or cervical surgery in the past. Results from this trial demonstrated 
that woman who had cerclage were less likely to have PTB < 33 weeks of gestation than 
those who didn’t have any intervention (13% versus 17%) but there was no difference in 
fetal or neonatal outcome. The overall preterm delivery rate was 28% which is normally 
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observed in high risk population. 25 women needed to be treated to prevent one preterm 
delivery. 
There were three more trials that looked at history indicated cerclage versus no intervention. 
Lazar et al66 looked at insertion of cerclage versus no intervention in 506 women with 
cervical incompetence and showed no significant difference  in preterm delivery rate (6.7% 
versus 5.5%). Rush et all67 looked at outcomes of pregnancy in 194 women who had 2 or 
more previous preterm deliveries before 37 weeks of gestation again there was no difference 
in outcome (34% in cerclage group versus 34% in no cerclage group delivering before 37 
weeks of gestation). Althuisius et al in CIPRACT trial68 recruited women based on history 
suggestive of cervical incompetence. Women had TVS measurement of the cervix. Twenty-
three women were randomised to prophylactic cerclage arm and 44 to no intervention group. 
The observational cohort had further random allocation to therapeutic cerclage and bed rest 
or bed rest alone when they had cervical shortening of <25 mm on transvaginal scan. 
No significant difference was found between the prophylactic cerclage group and the 
observational group in preterm delivery <34 weeks' gestation (3/23 vs 6/44, respectively).  
 As a result, the current NICE guideline14 recommends to offer history indicated cervical 
cerclage to women with history of three or more second trimester losses or preterm births. 
It doesn’t recommend to offer intervention such as cerclage to women who had fewer than 
2 SMTL or PTB. Ideally cerclage should be placed between 12 and 14 weeks of gestation 
in a planned elective manner. Currently there is no evidence to support pre-pregnancy tests 
for diagnosis of cervical insufficiency can be valuable in identifying women in whom history 
indicated cerclage can be beneficial. One observational study69 looked at 175 women with 
history of midtrimester loss assessing patient’s cervical resistance index. The consequent 
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cervical cerclage in these group of patients gave 75% successful pregnancy outcome, a 
result consistent with if conservative therapy would have been implemented. There was no 
control group either so no conclusions can be drawn69. 
Ultrasound indicated cerclage is offered to women with history of one or more SMTL or PTB 
whose cervix is found to be 25 mm or less on TVS. Four RCTs compared ultrasound 
indicated cerclage versus conservative management. 
Berghella et al70 randomised 61 women with the short cervix (25mm) to cerclage (n=31) 
versus no intervention (n=30). The primary outcome of the study was delivery before 35 
weeks. There was no difference found in those who had cerclage (14/31) compared to those 
who had no intervention (14/30). 
Rust et al71 randomised 113 women with short cervix  (<25 mm) to cerclage (n=55) versus 
expectant management (n=58). Again there was no significant difference in PTB rate 
between two groups (35% versus 36% respectively). 
To et al72 randomised 253 women with short cervix of<15 mm to cerclage (n=127) versus 
expectant management (n=126). The rate of PTB (delivery before 33 weeks) was similar in 
both groups. Cerclage group 28/127 versus 33/126 in control group (p=0.44). 
And the last RCT, mentioned above, CIPRACT by Althusius et68 al recruited women with 
obstetric history suggestive of cervical insufficiency. As a part of that large study 35 women 
were found to have a short cervix <25 mm on TVS. Of the 19 women who received a 
cerclage, none delivered before 34 weeks compared to 7/16 who had bed rest alone.  
There is some scepticism regarding outcome of those trials because of few issues. Al three 
trials, for example, included low and high risk women. Rust and Berghella included twin 
pregnancies, where pathophysiology of PTB is different to singleton pregnancy and cervical 
25 
 
length measurement, which requires intervention could be different as well. Both Rust and 
Berghella included women who had cervical funnelling on the scan irrespective of cervical 
length. The funnelling is very subjective finding on TVS to compare with cervical length. 
All studies took a cervical length “cut off” of 25 mm, apart from To et al who used “cut off” of 
15 mm, which can skew the data significantly as the risk of PTB increases exponentially 
below this measurement. 
The predicted probability of preterm delivery has been also linked to the cervical length. 
Berghella et al73 has proven that gestational age at which cervical length is measured as 
well as the length itself has a significant impact on prediction of spontaneous preterm birth. 
The conclusion from their study was that the cervical length is inversely related to the risk of 
spontaneous preterm birth, women with the shortest cervical lengths have the highest rates 
of spontaneous preterm birth. Their analysis suggests that the risk of PTB before 35 weeks 
decreased by 6% for each additional millimetre of cervical length (odds ratio 0.94, 95% 
confidence interval, 0.92-0.95, p=0.01). A subsequent systematic review confirmed that the 
shorter the cervical length the higher the positive likelihood ratio for spontaneous PTB before 
35 weeks of gestation74. 
As a result of this review cerclage can only be applied to an at risk population and  is not 
recommended for women with a short cervix and no history of SMTL or PTB75. Thus women 
who have an incidental finding of a short cervix on a transvaginal ultrasound scan should 
not be offered cervical cerclage as there is a lack of evidence of benefit. Also, it is just the 
cervical length which should be taken into consideration on scanning and predicting the 
probability of the preterm birth not the cervical funnelling. Women with incidental finding of 
cervical funnelling on transvaginal  scan should not be offered cerclage64. 
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The final type of cerclage is called emergency cerclage or in American literature physician 
indicated cerclage. It is a cerclage which is offered to women when they are found to have 
a dilated cervix with fetal membranes bulging into the vagina. This suture is offered 
irrespective of cervical length or history of previous preterm birth. There have been a number 
of trials looking at outcomes of rescue cerclage. Overall rescue cerclage can prolong the 
pregnancy on average for 5 weeks when compared to conservative management. This 
evidence comes from more than 25 retrospective observational studies and one RCT. The 
RCT looked at outcomes of rescue cerclage versus bed rest alone76. The rescue cerclage 
was followed by administration of indomethacin and antibiotics. The rate of the preterm birth 
was lower in this group as well as composite neonatal mortality when compared with controls 
(53.8% vs. 100%, respectively, P=0.02). The most recent evidence77 confirmed that 
antibiotics and indomethacin on their own made no difference to the prolongation of 
pregnancy. 
1.4.2 The procedure 
 
There are several types of cervical cerclage. Depending on the route of insertion of the stich, 
cerclage can be divided into abdominal and vaginal. Abdominal cerclage is now commonly 
performed laparoscopically or via mini-laparotomy. A robotic approach has recently been 
described.  Transabdominal cerclage (TA) is now usually offered pre-conceptionally and 
only occasionally inserted at 10-12 weeks of gestation under general anaesthesia78. It is by 
definition a history indicated cerclage. The 2 main indications for transabdominal cerclage 
is offered when the vaginal route is not possible or vaginal cerclage has failed previously. 
There is one single RCT comparing TA history indicated cerclage versus TV history 
indicated cerclage. The incidence of preterm birth was significantly lower in TA group (18% 
versus 42%)79.  
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The first operation described to treat cervical insufficiency was described by Lash A F and 
Lash S R and involved excision and repair of some part of the cervix, which they thought 
was leading to its weakness. The procedure fell into disrepute due to its high complication 
rate and subsequent incidence of infertility80. 
There are currently two surgical techniques used for vaginal insertion of cerclage. Both 
techniques carry the name of the doctors who invented them- Indian Dr Vithal Nagesh 
Shirodkar and Australian Dr Ian McDonald.  
In 1951 Dr Shirodkar initially successfully placed a catgut purse-string suture in a woman 
with recurrent miscarriage. Later he realised that catgut dissolves quite quickly and may not 
be very suitable for the procedure which is aimed to strengthen the cervix for a long period 
of time. He subsequently modified his operation using a strip of the fascia lata with linen 
suture81. He filmed his operation and presented his technique for the first time in 1951 at the 
Silver Jubilee Celebration of the French Society of Gynaecology. The case was published 
later in 1955 and described the successful outcome of pregnancy where the Shirodkar 
suture was used in a woman with cervical insufficiency 82. Two years later Dr I McDonald 
introduced a new technique83, which is now most commonly used. The first time it was used 
in a patient with a dilated cervix and bulging membranes this was in fact an emergency 
cerclage. He placed initially a catgut suture and then repeated the procedure 3 times on the 
same patient with an interval of few weeks. The outcome was a live birth at 34 weeks of 
pregnancy. Later he used non-absorbable silk instead of catgut for the same reason as 
Shirodkar and achieved good results. Thirty-three out of 70 women, who had emergency 
cerclage between 20 and 24 weeks of gestation, had a live birth with surviving neonates. In 
the rest of the pregnancies neonates died of extreme prematurity even though the 
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pregnancy was prolonged for 3-4 weeks.24 He published his retrospective series in the 
Journal of Obstetrics and Gynaecology of the British Empire in 1957. 
In both techniques a purse string is placed around the cervix. The Shirodkar technique is 
more invasive as it requires reflection and hence dissection of the bladder, takes longer to 
perform and can lead to more complication at insertion and removal point. The cerclage 
procedure is performed in theatre under regional or general anaesthesia in aseptic 
technique. 
Outcomes of different types of anaesthetics (general 
versus regional) were compared in an RCT of history-
indicated cerclage with the Shirodkar suture. There was 
no difference in rates of preterm birth 11.8%(general) 
versus 15.0% (spinal) or rates of second trimester 
miscarriage 5.9% (general) versus 10% (spinal).84  As 
the obstetric outcomes are the same and the safety 
profile for regional (spinal) anaesthesia is better, this 
method is now routinely recommended for the placement 
of a cerclage suture. 
The patient is placed on the table in dorsal lithotomy position, cleaned and draped with good 
exposure of the whole cervix in order to avoid injury to the vaginal tissues. Different surgical 
retractors are used for those purposes. 
Cleaning is performed with different solutions. Currently no data exists to confirm the efficacy 
of preoperative use of antimicrobial solutions versus none during cerclage procedure, 
although as data emerges about the microbiome, this in itself may become important. 
Usually chlorhexidine and povidone iodine are used if the patient has no allergies. Those 
Figure 5. Insertion of the 
Shirodkar suture  
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agents have been compared at the time of vaginal hysterectomy in RCT, where 
chlorhexidine was proven to be superior to povidone iodine, but it is unclear whether this 
can be applied to cerclage procedure85. 
 Currently the McDonald technique is the most commonly used procedure. The 
cerclage is placed at 12-14 weeks. A purse-string suture is placed round the cervix 
in 2-4 bites. The stich is placed anteriorly as close as possible to vesicocervical 
reflection and posteriorly as close as possible to uterosacral ligaments, capturing the 
stroma next to cervical canal78, avoiding 3 and 9 o’clock positions because of 
underlying paracervical vessels. During this procedure the bladder and rectum are 
not reflected, so surgeons should be particularly careful not to put the stich through 
those structures86. Once the suture is placed, the knot is tied anteriorly or posteriorly, 
again according to surgeon’s preference. The ends are left long enough to identify 
them later (usually 36-37 weeks of pregnancy) for removal. 
 The Shirodkar cerclage is similar but more challenging, as it requires bladder 
dissection so technically more difficult than McDonald’s method. The vesicocervical 
reflection is identified and mucosa over the anterior lip of the cervix is incised. The 
bladder is then mobilised via sharp and blunt dissection, the same as during vaginal 
hysterectomy, until the level of the internal os is reached. The cervix is grasped with 
ring forceps for traction and the mucosa on the posterior lip is incised in the same 
manner as in front to reflect the Pouch of Douglas and mobilize the rectum. A non-
absorbable suture is placed posteriorly to anteriorly in the cervical stroma and tied 
anteriorly obscuring the internal cervical os. The incisions on the mucosa are closed 
with absorbable suture burying the cerclage stitch. The Shirodkar procedure 
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sometimes involves a permanent stitch around the cervix which will not be removed 
and therefore a Caesarean section is recommended as the method of delivery.  
 
There have been several modifications to both methods of cerclage. For example, in 
Shirodkar cerclage knots should be placed posteriorly to avoid erosion into the bladder.  
Sometimes reflected mucosa are not sutured at the end of the procedure if haemostasis is 
adequate86. Surgeons used different sutures, a combination of different sutures and different 
types of needles. One of the most common modifications of Shirodkar suture is when the 
knot is buried under vaginal mucosa with a small part of the threads visible for removal. 
Quite often, the whole stitch is buried and patients go for elective caesarean section. Than 
the stich can be used for consecutive pregnancy if planned. If not, then suture is removed 
at the time of caesarean section under anaesthetic. 
Cervical cerclage is usually a day case procedure but in some units, patients are kept 
overnight. Variations in practice include the prescription of indomethacin for 24-48 hours.  
Restriction on physical activity or vaginal intercourse is not evidence based. Patients are 
discharged home with advice on bleeding per vagina, leakage of fluid, fever or 
tightenings/contractions. The suture is usually removed at 36-37 weeks, in an outpatient 
setting, to prevent the risk of tear to the cervix in case the patient goes into labour. Few 
cases of severe cervical lacerations have been reported when cerclage was left in situ till 
the onset of labour87. In 6% of cases suture removal requires regional anaesthesia and 
removal in theatre. Removal of cerclage maybe considered earlier then 36 weeks in case of 
preterm pre-labour rupture of membranes (PPROM), vaginal bleeding, signs of 
chorioamnionitis or if delivery is recommended because of concurrent obstetrical or maternal 
medical conditions (for example pre-eclampsia)88. With regards to PPROM, there has been 
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only one RCT that compared retention of cerclage versus removal in cases of PPROM. In 
this study statistically significant differences were not detected in prolongation of pregnancy, 
infection, or composite neonatal outcomes. But there was less infectious morbidity noted 
associated with immediate removal of cerclage.  
Initially a total of 142 patients should be included, based on sample size calculation. Interim 
analysis suggested that the conditional power for showing statistical significance after 
randomizing 142 patients for the primary outcome of prolonging pregnancy was 22.8%.  So 
the study was terminated after a total of 56 subjects were randomized (32 for removal and 
24 retention of cerclage). These findings “may not have met statistical significance if the 
original sample size of 142 was obtained, however they provide valuable data suggesting 
that there may be no advantage to retaining a cerclage after preterm premature rupture of 
membranes and a possibility of increased infection with cerclage retention89.” 
Few retrospective studies supported cerclage removal as it is associated with decreased 
levels of septic complications. 
If patients with existing cerclage develop uterine activity at any stage of the pregnancy, 
reinforcement with another suture has not been proven to be of any benefit 90. 
1.4.3 Type of suture material used 
 
Several suture materials have been used to perform the cervical cerclage procedure 
including Mersilene 5mm tape 65, 91, 92, Mersilene silk24, metal wire, human fascia lata82, 
Prolene71 and Nylon68, 93-96. Currently the most commonly used suture material is the 
Mersilene tape (a braided suture material/mesh) because of its perceived strength, reduced 
likelihood of tearing through tissues and ease of removal. 
 Implantable mesh devices have been used in surgery for a long time. Their use includes 
hernia repair, breast transplants and vascular surgery. Mesh is used in gynaecology mainly 
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for stress incontinence procedures and for prolapse surgery to give extra support to weak 
tissues. Modern use of mesh for the treatment of stress urinary incontinence (SUI) was 
described as tension free vaginal tape (TVT) procedure by Ulmstein in199797. The eventual 
material choosen was a type I polypropylene woven mesh and became extremely popular 
and widely used in urogynaecology with minimal complication rate in lon-term follow-up 
studies98. High recurrence rate of vaginal prolapse after primary surgery combined with 
success of TVT mesh led to the development of use of mesh in POP procedures. There was 
evidence to prove a beneficial use of mesh in urogynaecological surgery but recently use of 
those mesh devices has been questioned99 due to complications, such as erosion, 
expulsion, infection and pain, with mesh used for POP.100 
There are two main types of mesh used for POP procedures : biological  and synthetic or 
combination of different products. Biological derived from pig or cow tissue and non-
absorbable/synthetic is usually made from polypropylene.  
A first classification of synthetic meshes was suggested by Amid101 and was based on 
physical characterisctics of mesh devices. Lichtenshtein Hernia Institute also categorises all 
mesh products used for surgical purposes into four categories102. 
 
Table 1. Types of mesh 
Category Type of mesh 
I Macroporous  > 75 µM (Atrium® / Prolene®) 
II Microporous  < 10 µM (Gore-Tex®) 
III Macroporous with multifilamentous filaments (PTFE / Mersilene®) 
IV Submicronic (Silastic®) 
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Type IV mesh is not suitable to be used in soft tissues. Type II and Type III meshes are 
multifilament and have small pores which can confere a benefit to the smaller bacteria so 
they cannot be reached by the larger macrophages. As such a chronic infection100 can occur; 
as a result several Type II and Type III meshes have been abandoned in urogynaecology 
and ophtalmology. When such multifilament meshes are placed in the vagina, they behave 
like a wick103, allowing bacteria to travel up the mesh. Lilly in 1968 noticed the same effect 
happens in the oral cavity. When tissues are sutured with monofilament sutures (MOS) it 
causes less inflammatory reaction compared to multifilament (MUS) suture104. His 
hypothesis was supported later by Katz and Evans. They claimed that physical 
characteristics of suture material may be a major determinant of tissue response105. Lilly 
suggested that bacteria and oral fluids may be transmitted into a wound by a “wicking” action 
that would be more active in MUS than MOS.104 A very similar effect happens in the vaginal 
“cavity”, where vaginal secretions are drawn up all way through the mesh. Not only the 
structure of the mesh is important but also the environment it is exposed to has a major role. 
For example, Mersilene® (Type III mesh) has been used in a clinical study looking at POP 
surgery. In this study the patients underwent a sacrocolpopexy with the mesh which was 
placed either abdominally or vaginally.  The abdominal group had a 3% erosion rate whilst 
the vaginal branch had almost a 20% erosion rate106.  
Type I meshes have monofilament fibres and large pores ( > 90 microns). As a result it 
allows macrophages to get into the pores and speeds up the process of angiogenesis. As a 
consequence an initial inflammatory response settles quickly and leads to the formation of 
fibrous tissue around the mesh103. This leads to a low level of infection and 
erosion/extrusion. The majority of meshes used in stress urinary incontinence (SUI) and 
POP surgery are of Amid Type I100. 
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As a result of complications with mesh the FDA warned against mesh products specifically 
Type II and Type III meshes.  It also led to certain recommendations from RCOG regarding 
issues of mesh insertion and removal. NICE also currently supports the use of mesh for 
abdominal surgery for apical vaginal support as long as there are also arrangements for 
clinical governance, audit and consent.  
Any complications associated with mesh in mandated to be reported to Medicines 
Healthcare products Regulatory Agency (MHRA) as mesh is considered the medical device.  
As mentioned before, multifilament and braided sutures have been associated with an 
increased risk of infection especially when used in potentially non-sterile surgical fields 33. If 
the wick- effect produced by spaces between the suture strands happens around the cervix, 
it can lead to ascending genital tract infection, chronic cervical inflammation and 
chorioamnionitis due to the optimal environment for bacteria to multiply. Chronic 
inflammation takes place around the cervix. As a result, these multifilamentous mesh 
materials create a chronic inflammatory response, which ultimately results in the mesh 
becoming encapsulated in surrounding tissues and not being incorporated into them. The 
combination of encapsulation and the tail of the tape acting as a route for ascending infection 
result in the mesh being surrounded by an inflammatory exudate and ironically allows the 
mesh to be removed with relative ease and in one piece 34 which is the reason type one 
meshes cannot be used as they would be incorporated into the cervical tissue and could not 
be removed. 
  There is no clear evidence to date with regards to type of suture material to be used for 
cervical cerclage39. Currently the majority of the obstetricians use Mersilene tape ( braided 
tape, Type III). This practice is not supported by any evidence and is often determined by 
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personal choice or historical teaching. Mersilene tape is popular for its strength and relatively 
non-complicated removal. As it is a braidedsuture, it can stimulate a chronic inflammatory 
response and later be encapsulated, hencewhy it is easy to remove in one piece once the 
knot is cut. However , Mersilene has high absorbent properties and so acts as a wick. This 
wick may provide an environment where bacteria can grow and a route by which they can 
travel and enter the uterus where they may cause a chronic infection and stimulate early 
labour. The wick-effect of the multifilament material was confirmed by studies on Dalcon 
Shield, the IUD which was banned from use in 1970s because of the high rate of 
complications especially infection. Studies confirmed that multifilament thread, which 
consisted of 200-400 individual filaments, used in Dalcon Shield extended down into the 
vagina and was found to have a wicking effect in which bacteria-contaminated fluids were 
transported from the vagina into the uterus. 
The presence of multifilament braided suture material in the cervix when cerclage is placed 
predisposes to inflammation around the cervix, ascending infection which can lead to 
chorioamnionitis and in turn precipitates preterm birth. There are some studies confirming 
that microorganisms in the vagina are similar to those in amniotic sac in cases of 
chorioamnionitis. There are reports of an increased frequency of chorioamnionitis in 
premature cervical dilatation107 and increased risk of puerpal fever which is associated with 
cerclage65. It is well documented that identified infection, both acute and low grade, is the 
risk factor for preterm birth in almost 50% of cases108. Infection can spread 
haematogenously or via ascending route from the vagina. During healthy pregnancy fetus 
is protected from the ascending infection by several mechanisms and barriers. Firstly, the 
cervix which holds a mucus plug containing antibacterial substances109. This plug protects 
the sterile uterine environment from the vagina, which is full of bacteria. It has been named 
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“a gate keeper” by some authors110 which claim there is an association between impaired 
function of the cervical plug and preterm birth. A cervical mucous plug is approximately 10g 
in weight, is produced by secretory cells in the endocervical canal where the plug is located 
in pregnancy. The cervical plug contains mucins (large glycoproteins). They prevent 
diffusion of bacteria and inhibit viral replication. Also, a mucosal plug has immunological 
properties which can arrest bacterial infection by stimulating a robust inflammatory 
response. Besides all that, a cervical plug contains numerous antibacterial substances such 
as lysozyme, antimicrobial polypeptides, lactoferrin, calprotectin, alfa-defensin and betta-
defensin. When their concentration is low it may predispose to the onset of preterm labour 
or premature rupture of membranes followed by preterm delivery109. 
The suspected wicking and associated peri-cervical infection as a result of Mersilene is 
prompting many specialists to move towards the adoption of monofilament sutures such as 
Prolene or Nylon. Conversely monofilament sutures are thought to be weaker and can 
possibly traumatise the cervix at the time of insertion and removal.  But ironically in surgery, 
if there is concern about tissues one would opt for a monofilament, so the argument in terms 
of less trauma at insertion is theoretically flawed, but the arguemnt of the monofilament 
“cheese wiring” or cutting through the cervix in the presence of inflammation remains.  
To date the characteristics associated with these meshes or tapes have not been considered 
with regards for the potential for the Mersilene® tape to contribute to premature delivery.  
1.5 Research hypothesis 
  
 Therefore, I have hypothesized that any increased risk of infection and chronic inflammation 
around the cervix associated with a braided suture material such as Mersilene tape could 
be a major confounding factor for underestimating the true benefit of cervical cerclage39. I 
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hypothesised that as braided sutures would have been the predominant type of suture used 
in the studies included in the Cochrane report, they may have unintentionally induced a bias 
in the conclusions and possibly masked a real benefit of cervical cerclage. It is possible that 
some obstetricians are aware of or suspect this link and that is why they prefer to use non-
braided monofilament sutures such as Nylon or Prolene for the cervical cerclage. Our survey 
findings (see chapter 5) confirm that almost one in five obstetricians performing cervical 
cerclage use monofilament sutures. But this choice is not evidence-based. The impact of 
suture material on the outcome of a surgical procedure should not be ignored. There are 
examples in medical literature where change of type of suture material has unmasked the 
effectiveness of the surgical procedure which was previously unrecognised111. In the 
Cochrane review by Kettle et al change of suture material, (use of synthetic sutures instead 
of catgut111), was associated with less perineal pain and analgesia requirements ten days 
postnatally, after episiotomy and second degree tears. Women who had synthetic sutures 
used for second degree tear repair had less re-suturing episodes. The lack of clear and 
widely accepted criteria for inserting a cerclage is another possible reason for the inability 
of the current literature to demonstrate a clinical benefit of cerclage procedures. 
Up to this day researchers have investigated different aspects of cerclage procedure in 
relation to the type of procedure (McDonald or Shirodkar), number of sutures places (one 
versus two), timing of the procedure (at which gestation it is the best to insert the suture) 
and eligibility criteria for insertion112-114. Some researchers did look at outcomes of 
pregnancy depending on different type of suture material used in cerclage, but they didn’t 
include monofilament sutures96. For example, Berghella et al looked at the outcomes of 
pregnancies in patients with ultrasound indicated cerclage, comparing Polyester braided 
thread (Mersilene or Ethibond) and polyester braided Mersilene tape. Both sutures had the 
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same efficacy96.  So to our knowledge no published RCT or NRS has compared the use of 
braided suture materials to non-braided monofilament sutures. 
In order to test my hypothesis few steps were undertaken. 
1. Initially a retrospective analysis of the cohort of pregnant women who had cervical 
cerclage with Nylon (monofilament non-braided) and Mersilene (braided) in two units 
in the UK. This analysis revealed that use of Nylon is associated with higher rates of 
successful pregnancies (95% compared to 88% respectively) - Chapter 2. However, 
it was a retrospective study and it is well known that non-randomised studies 
evaluating an effectiveness of a surgical procedure are prone to potential bias and 
overoptimistic results regarding a new technique or new therapy115. 
2.  In collaboration with Birmingham Clinical Trials Unit (BCTU) and the RCOG I have 
conducted a national survey of O&G Consultants in the UK, which confirmed 
variability in practice.  The majority of respondents were using Multifilament (braided) 
sutures and only 13% used Monofilament sutures. The second important observation 
was that 75% of respondents were not sure about which suture material is best to 
use - Chapter 4. 
3. We have undertaken systematic reviews, which identified no RCTs that have 
addressed this question. Therefore, we extended our review to include all types of 
studies with no language or time restriction. A meta-analysis of non-RCT studies 
investigating cerclage outcome by type of suture material used demonstrated that 
monofilament cervical suture is associated with a significant risk reduction in 
associated pregnancy loss compared to multifilament/braided sutures (RR 0.32 95% 
CI 0.19 - 0.53) - Chapter 3. 
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2.1 Objectives 
 
The concerns raised in relation to specific multifilament meshes in respect of gynaecological 
and surgical practice have not led to an awareness of the potential problems of their use in 
obstetrics, nor has there been any apparent change of practice in obstetrics. With the 
support of colleagues from Addenbrookes Hospital, I performed a retrospective review of 
elective cervical cerclage carried out in two large UK teaching hospitals (Birmingham 
Women’s Hospital and Addenbrookes Hospital).  The main objective of this review was to 
study the outcomes of singleton pregnancies considered to be at risk of preterm delivery or 
midtrimester loss in relation to the two suture materials used, Prolene and Mersilene tape. 
 
In the first Unit (Birmingham Women’s Hospital NHS Foundation Trust) only a few 
Consultants were involved in performing cervical cerclage and used either Mersilene tape 
or Prolene suture. The majority of the Consultants in Birmingham used the McDonald 
technique for cervical cerclage. The role of Shirodkar cerclage was reserved predominantly 
for the patients with previous failed McDonald cerclage, short cervixes after previous 
treatment (LLETZ, cone excision et cetera). In Addenbrookes Hospital only two Consultants 
performed cervical cerclage. One routinely used Mersilene tape and the other Prolene 
suture. 
2.2 Methods 
 
Obstetric theatre databases were hand searched to identify patients who had undergone 
cervical cerclage. The data was cross referenced with the Obstetric databases at both 
centres. Notes were identified where possible and details collected on an anonymised 
proforma (see Appendix 1). Data from other hospitals was sought if delivery occurred in 
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units other than the hospital where the cervical cerclage took place. No attempt was made 
to stratify for the complexity of the case or control for other confounding variables. 
Information about the procedure including cerclage type, suture material used, gestation at 
insertion, indication for insertion and nonviable birth (stillbirth or miscarriage) was collected. 
Other data collected included gestation at removal; gestation at delivery; mode of delivery; 
previous preterm birth or midtrimester loss; indication for cerclage; and relevant 
microbiological data. 
Outcome was defined as either: 
A composite of fetal demise prior to delivery or nonviable birth (delivery < 24 weeks of 
gestation or intrauterine death) delivery before 34 weeks of gestation. 
Analysis was performed using Graphpad Instat 3.06.  Intergroup comparisons for continuous 
variables with a non-parametric distribution were made using the Mann-Whitney U test to 
determine significant differences between the data sets. For such data, median values and 
95% confidence interval (CI) are described. Categorical data was analysed using Fisher's 
exact test and odds ratios and 95% CI. Significance was taken as P<0.05 unless otherwise 
stated. 
2.3 Results 
 
Data were collected between January 2002 and December 2008 and 102 cases of elective 
cervical cerclage were identified. There was no record of suture material used in two patients 
and one had an abdominal cerclage procedure. No outcome data was available due to 
pregnancies delivering elsewhere and being lost to follow up in a further three cases. Thus 
ninety-six cases of elective cerclage had sufficient data and were analysed.   
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In majority of cases the procedure was performed by a Consultant. Even when it was 
performed by sub-speciality trainee (SST) or Registrar, it was under direct supervision of a 
Consultant, according to the notes Fig 6. In some notes this information was missing. 
 
 
Figure 6. Grade of operating surgeon  
 
Of 96 elective cerclage cases, forty underwent cerclage with monofilament Prolene® non-
absorbable suture (41.6%) and fifty-six had Mersilene tape inserted (58.4%) Fig 7. 
 
 
Figure 7. Type of suture material 
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For descriptive purposes we include details of the cerclage performed. Twenty-two were 
Shirodkar (22.9%) and seventy-four McDonald cerclage (77.1%) Fig 8.  
 
Figure 8. Type of cerclage procedures  
 
Of the twenty-two Shirodkar cerclage, eleven (50%) had a monofilament Prolene® suture 
and 11 had Mersilene tape insertion (50%). Fig 9. In the pregnancies undergoing 
MacDonald cerclage, twenty-nine had a monofilament Prolene® suture (39.2%) and forty-
five Mersilene tape (60.8%). Fig 9.  
                      
Figure 9.Types of suture material depending on cerclage technique 
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Thirty-eight of the forty patients who underwent Prolene® suture cerclage had live born 
children. In one, there was an intrauterine death (IUD) at 19 weeks and in the second, 
emergency Caesarean at 25+2 weeks with neonatal demise. Data was available on all forty 
patients who had undergone cerclage with Prolene® suture in relation to gestational age at 
delivery. Thirty-two (80%) delivered at a gestation over 34 completed weeks. In five cases, 
delivery was between 25-29 weeks (median 28 weeks [95% CI 24.7-29.3]) and there was 
on early neonatal death at 25+2/40 (20%). 
We could only retrieve data from maternal notes, as a result documented follow up was only 
up until discharge. We didn’t have access to neonatal data so late neonatal deaths, if any, 
were not included in this analysis. 
So in those women who had Prolene inserted for cerclage there was a 95% take home baby 
rate.  
Of the 56 women undergoing Mersilene suture cerclage, forty-nine had live babies, seven 
had fetal demise. In these cases, 6/7 (85.7%) ended in miscarriage and 14.3% (1/7) in 
stillbirth at a gestation of 29+5/40 weeks (95% CI 16.7-23.9). Of these seven cases, the 
mean time of suture insertion to identified fetal demise was 6.5 weeks (range). 
In summary those patients who had Mersilene used for cerclage had “take home baby” rate 
of 87.5%. Table 2. 
Based on our results, Prolene suture cerclage appears to be associated with 5% risk of fetal 
demise and Mersilene suture a 12.5% risk of fetal demise (Fishers exact p=0.2). By 
operation type, 1/22 (4.5%) patients undergoing Shirodkar cerclage suffered perinatal loss 
compared with 6/73(8.2%) undergoing McDonald cerclage (Fishers exact p=1). 
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Table 2. Demographic data and perinatal outcome in both suture types 
 Multifilament suture n=56/102 
(58.4%) 
Monofilament suture n=40/102 
(41.6%) 
Age Mean age 30.3 (range 46-28) Mean age 35.8 (range 48-31) 
Parity Mean 2 (range 0-4) Mean 2.3 (range 0-5) 
Indication for 
cerclage 
All Elective All Elective 
Gestation at 
insertion 
Mean 13.2/40 weeks Mean 14.3/40 weeks 
Type of procedure 
Shirodkar 
N=11/56 N=11/40 
Type of procedure 
McDonald 
N=45/56 N=29/40 
Gestation at removal Mean 36.3/40 weeks  Mean 36/40 weeks 
Viable (live) N=49/56 N=38/40 
Delivery >34/40 N=41/56 N=32/40 
Delivery <34/40 N=7/56 N=8/40 
Non-viable N=7(6 midtrimester loss+1 stillbirth), 7/56 
(12%) 
N=2 (1midtrimester loss+ 1 neonatal 
death), 2/40 (50%) 
Gestation at delivery Mean 35/40 weeks Mean 35+3/40 weeks 
Mode of delivery C/S – 16/50 
NVD – 34/50 
C/S – 12/39 
NVD – 26/39 
Take home baby rate N=49/56 (87.5%) N=38/40 (95%) 
 
We have looked at data on evidence of infection in the women where there was a reason to 
be clinically suspicious. In the monofilament group eleven (27.5%) patients had no swabs 
taken. Of those forty who had a swab; twenty (50%) had no growth. The remaining nine 
(22.5%) had positive cultures: six had group B haemolytic streptococcus, two had evidence 
of bacterial vaginosis and one had candida.  
 
Of the Mersilene group twenty-two (40%) did not have any microbiological data available; of 
those that did, seventeen (31%) had no growth, eight (15%) had group B haemolytic 
streptococcus, five (9%) had Candida Albicans, two had bacterial vaginosis, one had 
evidence of unspecified anaerobic infection and one had Actinomyces. Fig 10. 
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Table 3. Microbiological data  
Type of suture No swabs taken  No growth Positive cultures 
Prolene/Nylon 
N=40 
N=11 (27.5%) N=20 (50%) N=9 (22.5%) 
 
Mersilene tape 
N=56 
N=22 (40%) N=17 (31%)  N=17 (30 %) 
 
 
 
Figure 10. Results of positive microbiological swabs in Mersilene group. 
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Figure 11. Results of positive microbiological swabs in Prolene group 
In the monofilament group who delivered prematurely (7) (<34 week delivery) two had group 
B haemolytic streptococcus, five had no growth. In the Mersilene group, who delivered 
prematurely two had Candida Albicans, one had bacterial vaginosis, four had no growth and 
three had no microbiological data available. 
 
There was no difference in the incidence of positive microbiology in the women who 
delivered before thirty-four weeks and those which delivered after thirty-four weeks. 
 
2.4 Discussion 
 
Our study was limited by its retrospective nature and the relatively small number of cases. 
However, even with small numbers, it did reveal a significant difference in fetal loss 
depending on type of suture material used (12.5% versus 5% with Multifilament and 
Monofilament groups respectively). 
As mentioned in the previous chapter, there are good reasons as to why experience with 
monofilament and multifilament mesh and sutures in other areas of medicine might be 
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pertinent to obstetric surgery. Common complications of multifilament meshes, such as 
infection and erosion, may suggest that the use of Mersilene tape leads to an alteration in 
the integrity of the native cervical tissue.  It also predisposes to an ascending infection and 
also because of the mesh construction may prevent the host tissue’s ability to mount an 
appropriate defence against bacteria. Chronic inflammation around the cervix may be 
implicated in a weakening of the cervical and para-cervical tissues and in particular would 
explain the increased puerperal fever seen in previous reports of cervical cerclage65. 
Monofilament and Multifilament sutures display similar characteristics to the mesh implants. 
In addition, multifilament sutures demonstrate a potential for increasing capillarity 
characteristics which may increase fluid and bacterial movement, potentially increasing the 
risk of ascending genital tract infection, chronic cervical inflammation and chorioamnionitis. 
 
Retrospective studies usually have errors due to confounding factors and bias. The most 
significant confounding factors was absence of information in all the notes on previous 
cervical surgery such as LLETZ procedures, previous cerclages and information about 
concurrent medication used before or after cerclage, for example Cyclogest pessaries. The 
insertion of the cervical suture wasn’t standardised procedure and possibly could have 
varied operator dependant. Majority of the trainees (SSTs and Registrars) used Mersilene 
tape whether Consultants involved in cerclage service were using Monofilament suture more 
frequently.  Potentially skills of the operating surgeon could have influenced the outcome as 
well. Again due to retrospective nature of the review information about technique of cerclage 
procedure itself and grade of the operating surgeon wasn’t recorded in every set of notes. 
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The main strength of this review was that it was conducted relatively quick initially and during 
preparation for HTA, without significant expenditures which is one of the main advantages 
of these type of studies.  
I have achieved the main objective of this retrospective review which was to look at the 
outcomes of pregnancies depending on type of suture material used in cerclage procedure 
to prevent preterm delivery or midtrimester loss. Based on the findings of this retrospective 
analysis, we hypothesised that increased risk of infection and pericervical mesh 
inflammation is associated with braided suture material, such as Mersilene tape, used for 
cerclage and can be a significant confounding factor for the underestimation the true 
effectiveness of the cervical cerclage procedure. 
In order to support our research hypothesis based on this retrospective analysis of a cohort 
of pregnant women who had cervical cerclage using either Nylon (Monofilament) or 
Mersilene (Multifilament) where the former was associated with higher rates of successful 
pregnancies, I have undertaken a systematic review of the medical literature for both 
randomised and non-randomised observational and cohort studies that investigated 
cerclage outcome by the type of suture material used.  This is presented in the next chapter. 
2.5 Conclusion 
 
In preparation for an application to Health Technology Assessment (HTA), I have extended 
retrospective data analysis to December 2012 and looked through an additional one 
hundred and fifty-six notes. The results of additional data (only one hundred and five cases 
included after data clearing) were combined with similar data from another five UK University 
hospitals giving a total number of six hundred and seventy-one women who had planned 
cervical cerclage. The data was published recently116.  The results of retrospective analysis 
re-confirmed that in women receiving cerclage with Mersilene tape there are higher rates of 
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fetal demise (intrauterine death and delivery before twenty-four weeks) when compared with 
those receiving the monofilament suture (15% versus 5% respectively; p<0.0001) as well as 
preterm labour (28% Mersilene versus 17% Monofilament sutures; p<0.0001). 
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Use of different suture material multifilament braided sutures versus monofilament 
non-braided sutures in planned (elective) cervical cerclage: Systematic review and 
meta-analysis 
 
 
3.1 Objectives 
 
1. To systematically review the literature to identify different types of suture material 
used for planned/elective (history-indicated, ultrasound indicated) vaginal cervical 
cerclage 
2. To systematically review, and if possible, to meta-analyse data from the literature to 
determine pregnancy outcomes depending on type of suture material used in 
planned/elective vaginal cervical cerclage 
3. To systematically review, and if possible, to meta-analyse data from the literature to 
identify adverse outcomes associated with cerclage especially rates of pregnancy 
loss and infection  
4. To use the findings of this review in order to support the hypothesis for this thesis and 
development of research protocol for COTS pilot/feasibility study 
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3.2 Abstract 
 
Objective 
To determine the effectiveness of different suture materials used in planned/elective (history 
or ultrasound indicated) cervical cerclage. 
Methods 
Studies were identified through systematic search without language restrictions from 
MEDLINE (inception to 2016), EMBASE (inception to 2016), CINAHL and Cochrane Library, 
and manual searching of bibliographies of known primary and review articles. Studies were 
selected if women with previous pregnancy loss or history of preterm birth had history 
indicated or ultrasound indicated vaginal cervical cerclage. In a view of absence of RCTs 
comparing type of suture material in relation to planned/elective cerclage the search was 
extended to non-randomised studies (NRS) such as observational studies and case series 
were included. Data were extracted on study characteristics, quality and the outcome such 
as pregnancy loss. Relative risks from individual studies were meta-analysed using random 
and fixed effects models. Heterogeneity was evaluated graphically using forest plots and 
statistically using the I2 statistic. 
Results  
The NRS meta-analysis demonstrated that non-braided sutures, compared to braided, were 
associated with a pregnancy loss rate of 4% compared to 15% respectively (RR 0.32 95% 
CI 0.19 - 0.53). 
Conclusion 
The NRS meta-analysis demonstrated that there is evidence to suggest that pregnancy loss 
is less in women undergoing planned (elective) cervical cerclage when un-braided 
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monofilament suture material is used. This review was limited by the quality, number and 
size of included studies. Also, there is no doubt that studies which do not involve 
randomisation are liable to potential bias. Hence there is a need for a randomised controlled 
trial to address this issue.  
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3.3 Introduction 
 
Preterm birth remains the leading cause for perinatal mortality and morbidity worldwide with 
colossal implications for healthcare costs and the affected families caring for children 
affected by mental and physical disabilities as a result of PTB. Management of preterm birth 
remains one of the most challenging areas of modern obstetrics. There are few 
interventions, specified recently in Born Too Soon report, which have improved outcome of 
the PTB. Cervical cerclage was one of them and occupied the third place after smoking 
cessation and decreasing multiple embryo transfer during assisted reproductive 
technologies. It has been used for this purpose for decades. Recently it has become more 
popular especially in a view of flawed evidence related to Arabin pessary and findings from 
OPTIMUM confirming60 that progesterone is not effective in the second trimester to prevent 
pregnancy loss. Irrespective of that some researches are still trying to compare all three 
treatments in single study (SuPPoRT trial)63. It has been proven that cervical cerclage can 
be very effective, especially in women with a history of previous PTB and/or short cervix on 
transvaginal scan. It reduces the rate of PTB in this cohort of women up to 20%. 
In the UK cerclage is offered to women at risk of PTB or mid-trimester loss, as per the NICE 
recommendations14, but the evidence from the recent survey states that quite often that 
practice can be sparse, not evidence based and often completely relies on personal 
preferences of the obstetrician involved, regarding patient selection, gestation at insertion 
and preferences on suture material used during the procedure, even though the perceived 
“golden standard” is Mersilene braided tape. So, there is a lack of consensus regarding 
several aspects of the procedure: timing of insertion (pre-conception, in first trimester 
ultrasound indicated or history based); optimal technique for cerclage insertion (vaginal or 
abdominal; if vaginal then Shirodkar or McDonald (both proven to be equally efficacious in 
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women with short cervixes); low or high; single/double sutures/pursue string; position of the 
knot anterior or posterior; type of suture material used. The mechanism of action for cerclage 
is also poorly understood but there is a theory that suture itself provides a mechanical 
support as well as keeping the cervical plug intact from ascending bacteria, thus protecting 
the fetal membranes from rupturing. Cervical cerclage is associated with infection and it is 
clearly stated in the first randomised trial on cerclage from 30 years ago as well recent data 
from Cochrane review. Possibly type of suture material used in procedure can play a role? 
It has already been proven in other disciplines that type of suture material can have 
significant impact on the outcome of surgical procedure. 
 
Cervical cerclage remains the primary choice of treatment in many specialised preterm birth 
clinics and is an increasingly performed procedure. It is identified in the “Born Too Soon” 
report by World Health Organisation (WHO) as one of the five most important interventions 
to prevent preterm birth. Based on the WHO survey results 45% of Consultants in Preterm 
Birth specialised clinics in UK use cervical cerclage as their primary choice of treatment in 
women at risk. The NICE supports the use of cervical cerclage in a selected population14. 
Several techniques have been advocated for the insertion of a suture but the most popular 
ones are McDonald and Shirodkar when suture is placed around the cervix with or without 
bladder dissection with intention to prevent dilatation, keep mucosal plug in situ and prevent 
anticipated midtrimester miscarriage or preterm birth. Traditionally Mersiline suture has been 
used for cervical cerclage but monofilament sutures such as Prolene or Nylon are also in 
use even though not so popular due to technical difficulties of insertion and removal as well 
as the theory that it may not provide as effective mechanical support as a wide and strong 
Mersilene tape. As discussed in chapter 1, section 1.3, meshes especially braided ones are 
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associated with high risk of infection and guidance has been issued to restrict or prohibit 
their use in many surgical specialties. 
A question of safety of cervical cerclage has been raised many decades ago in an MRC 
study65 where cases of puerpal fever were reported associated with cerclage. Type of suture 
material used for cerclage 30 years ago wasn’t considered as a possible cause of infection 
associated with cervical cerclage. There is a recent evidence supporting link between 
cerclage and infection. A systematic review by Saccone et al117 also raised concerns about 
safety of this surgical obstetric intervention. 
The aim of this review was to systematically analyse the available literature to assess the 
outcomes of pregnancies where women had planned/elective vaginal cervical cerclage, 
depending on type of suture material used during the procedure and to identify where use 
of multifilament braided sutures versus monofilament un-braided sutures has any impact on 
pregnancy loss. 
 
3.4 Methods 
 
3.4.1 Identification of literature 
We searched databases for relevant published literature on outcomes of planned/elective 
cervical cerclage depending on type of suture material used during the procedure, with 
particular attention to pregnancy loss. We searched the following electronic databases: 
MEDLINE (from inception to November 2016), EMBASE (from inception to November 2016) 
and Cochrane Central Register of Controlled Trials (CENTRAL). A search strategy was 
carried out based on the following key words and/or medical subject heading (MeSH) 
terminology: ‘cervical cerclage’; ‘elective cerclage’; ‘uterine cervix cerclage’, ‘vaginal 
cerclage’; ‘short cervix’; ‘sutures for cerclage’, ‘sutures’. Key words were combined using 
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AND/OR. I did not include term rescue cerclage as we only were interested in the outcomes 
of planned cervical cerclages, those performed as indicated on transvaginal ultrasound scan 
because of shortening cervix or history based ones.  Rescue cerclage is performed when 
patient presents with a dilated cervix and membranes bulging into vagina. 
 Electronic searches were complemented by hand searches. In addition, references from all 
identified articles were checked. The search was not restricted by language. The searches 
were conducted independently by FI and another reviewer HH. 
 
3.4.2 Study selection  
 
Studies were selected if the target population were women who had a cervical cerclage. All 
articles about emergency cerclage as well as laparoscopic cerclage were excluded from the 
start, i.e only elective (planned) vaginal cerclage procedures were included.  The primary 
outcome was defined as pregnancy loss depending on type of suture material used. The 
pregnancy loss was defined as second trimester miscarriage, intrauterine death in 
pregnancies where cervical cerclage was inserted or early neonatal death.  
Table 4. PICO table 
Acronym Definition Description 
P patient or problem Women who had cervical 
cerclage 
I Intervention Monofilament suture 
C control or comparison Multifilament suture 
O Outcome pregnancy loss 
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First, the titles and abstracts from the electronic searches were scrutinized by two reviewers 
independently (HH and FI) and full manuscripts of all citations that were likely to meet the 
predefined selection criteria were obtained. All case reports, letters to editor and 
commentaries were excluded. A final decision on inclusion or exclusion was made by two 
reviewers on examination of the full manuscripts. In cases of duplicate publication, the most 
recent and complete versions were selected. There were no disagreements about inclusion 
but the plan was such a case to occur was review by third potential reviewer (PTH) with 
resolution by arbitration. Data extraction was performed in duplicate by HH and FI. 
Information was extracted from each selected article such as study characteristics, quality 
and outcome data and entered on to a data extraction form. 
 
3.4.3 Methodological quality assessment 
 
We were unable to identify any RCT comparing type of suture material used for cerclage, 
so NRSs were used alone. The studies were assessed and selected using the Newcastle-
Ottawa Scale (NOS)118 which is  commonly used as an assessment tool for non-randomised 
studies, especially cohort ones and case-control. Assessment criteria for case-controlled 
and cohort studies are different but they all cover 3-4 main domains such as the selection 
of participants, comparability of cohorts and the ascertainment of exposure (for case–control 
studies) or outcome of interest (for cohort studies). Stars are used to rate the quality of each 
criteria in the domain. One star is awarded as maximum for all items except for comparability 
where a maximum of two stars can be given. This assumes that all items included into 
Newcastle-Ottawa Scale have equal weight. The score ranged from 0 to 9, with a score of 
either 0 or 1 for each item.  
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 The scale was developed by two big Universities one in Australia- University of Newcastle 
and the other one in Canada, Ottawa University. The first time scale was presented more 
than 10 years ago in Oxford, UK at the Third Symposium for Systematic reviews119 and now 
has a full support of The Cochrane Collaboration for the use of non-randomised studies120. 
 All selected studies were evaluated for: 
- Selection: 1) representativeness of the exposed cohort; 2) selection of the non-
exposed cohort; 3) ascertainment of exposure; 4) demonstration that outcome of 
interest was not present at start of study. 
- Comparability: 1) comparability of cohorts on the basis of the design or analysis 
- Outcome: 1) assessment of outcome; 2) was follow up long enough for outcomes to 
occur; 3) adequacy of follow up of cohorts. 
The risk of bias was considered as low if a study gathered four stars for selection, two for 
comparability and three for ascertainment of exposure. The risk of bias was medium if study 
had two or three stars for selection, one for comparability and two for exposure. The high 
risk of bias was granted if study was scoring zero stars for selection, comparability or 
exposure. 
We planned to use quality assessment in subgroup analysis to explain any observed 
heterogeneity. To detect publication and related bias, we were planning to do funnel plot 
analysis using Egger’s tests to evaluate asymmetry. 
 
3.4.4 Data synthesis 
 
A data extraction form was designed to retrieve relevant information from selected studies. 
The second reviewer (HH) extracted data using the agreed form. Any disagreements were 
resolved by discussion.  
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Analysis was by pooled odds ratios from individual studies in order to use random effects 
model. Analysis was performed using Revman 5.3 statistical software. Relative risks with 
95% confidence intervals from each study were combined for meta-analysis using the 
Mantel-Haenszel method.  Data was combined from observational studies and used the 
random-effect model assuming that studies estimated the same treatment effect: i.e. where 
trials are examining the same intervention, and the trials’ populations and methods were 
assessed sufficiently similar. Heterogeneity effects were assessed graphically using forest 
plots and statistically using chi-squared and I2 test.   
3.5 Results 
 
The initial search performed in 2012 revealed 351 publications from 3 databases (MEDLINE 
128, EMBASE 215 and CINHAL 8) with 87 duplicates which were excluded leaving 264 
references. This search was performed as a part of preparation for COTS trial and 
application for HTA grant. Before submission of this thesis the search was repeated and 
extended from March 2012 to November 2016. A further 123 publications from 3 databases 
were identified (MEDLINE 34, EMBASE 83 and CINHAL 6) with 32 duplicates which were 
excluded leaving 91 references to be included into systematic review. There were no 
randomised controlled trials identified.  So overall 474 publications were identified. From 
them 119 duplicates were removed and the remaining 355 manuscripts abstracts were 
revised. From the title and abstract, 302 studies were excluded as it was clear that they did 
not fulfil the selection criteria. Full manuscripts were obtained for the remaining 53 articles: 
from these 49 studies were excluded. Therefore, 4 studies reached the inclusion criteria. 
There were insufficient data available on 2 of them and after contacting authors it was 
excluded from the review leaving 2 papers. When we have assessed them using Newcastle-
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Ottawa scale, they had low risk for bias and were included into meta-analysis. Figure 12 
demonstrates the study selection. 
First one, by Kindinger et al116, is of a retrospective nature, which undermines its quality but 
on the other hand the sample size is large and covers few centres in UK. This study also 
includes a prospective cohort but patient was only followed up until 16 weeks of pregnancy 
in two different cohorts (multifilament versus monofilament). The outcomes of pregnancy in 
prospective cohort are not presented. The retrospective review though includes data from 
large UK centres (including data from our retrospective analysis) and outcomes for preterm 
birth rate were similar in each of them. The authors give all the details of cerclage insertion 
such as gestation at insertion, indication for cerclage, suture material used and outcomes of 
PTB and nonviable birth. They also specify metadata such as age, parity and previous 
obstetrical experience of the included patients. They present clear statistical evidence of 
favourability of monofilament material over multifilament comparing rates of pregnancy loss 
in both cohorts of patients (15% versus 5%, respectively; with P<0.0001). Apart from 
pregnancy loss they present rates of PTB which is again higher in patients who received 
braided suture cerclage (28% versus 17% respectively; P<0.0001). 
The second paper, by Shoenfield et al is poorly controlled. Even though it is a randomised 
trial, the authors did not specify what kind of randomisation was used, the numbers were 
small (10 in each arm only). The patient selection criteria were not very clear with single 
specification that randomised patients had proof of cervical incompetence. The exact 
inclusion and exclusion criteria are not given. The authors also declared that they evaluated 
suture materials used for cerclage. Their conclusions were based on post-procedure 
complications and pregnancy outcome. The main limitation of the study is that neither those 
complications nor pregnancy loss itself are specified. The pregnancy loss, which is a primary 
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outcome, is not specified in details whether it is midtrimester miscarriage or intrauterine 
death or neonatal death. They also did not give any data on gestation of insertion or removal 
or gestation at which pregnancy loss has happened. A further limitation was absence of any 
data on neonatal outcome, admission to the neonatal unit, short or long term follow up.  
On another hand, they described in detail the methods of investigations used for suture 
material used in cerclage such as (scanning electron microscopy (SEM) with the use of 
cathodoluminescence and X-ray diffraction analysis). They also investigated the sutures 
before and after insertion (on removal). Both methods proved that monofilament suture 
didn’t change in structure and its surface remained unaffected. Alternatively, SEM method 
proven that multifilament tape was covered with specific “coating” which consisted of 
mucoproteins and phagocytes and X-ray analysis found significant changes in structural 
degradation of the fibres of the tape after use. The authors link presence of coating to 
infection rate in 4 out of 10 patients who had cervical cerclage with braided tape. They 
demonstrated that the monofilament suture didn’t have such a cover after use and as result 
had a better outcome, such as there were no pregnancy loss in 10 patients who had the 
monofilament cerclage. Again the quality of the outcome was poor as it did not specify the 
gestation at which patients delivered, mode of delivery and neonatal data. 
 
 
 
 
 
 
64 
 
Figure 12 Study selection process for systematic review of type of suture material 
used in planned/elective vaginal cervical cerclage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systematic review flow chart 
Total number of citations retrieved form electronic searches 
and from examinations of reference lists of primary and review 
 
Duplicates: n=119 
Full manuscripts retrieved for detailed evaluation: n= 355 
Articles excluded after review of 
full texts did not fulfil the selection 
criteria or were in a foreign 
language: n= 302 
53 articles remaining, full 
manuscripts obtained 
48 studies excluded 
5 studies included Authors contacted 
2 studies included in final 
analysis 
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Table 5 Appraisal of methodological quality by Newcastle Ottawa Scale 
*- Indicates that feature is present; - indicates that feature is absent. For comparability by 
design this checklist awards a maximum of 2 stars (**) and (*) or none if the feature is 
completely absent. 
 
3.5.1 Study characteristics 
 
Two studies included a total of 691 women. The study characteristics including sample 
population, number of women, type of cerclage and outcome of pregnancy presented in 
table 6. 
Table 6. Study characteristics 
Author, year Sample 
population 
Patient 
number 
Study design Outcomes 
measure 
Shoenfeld et al 
1999 
Women with cervical 
incompetence 
20 Randomised, type of 
randomisation not 
specified 
Pregnancy loss 
Kindinger et al 
2016 
 
Women receiving 
planned cervical 
cerclage 
671 Retrospective cohort 
study 
Non-viable births 
(delivery before 24/40 
or intrauterine death) 
 
It is worth mentioning about studies which we didn’t include in analysis. First one looked at 
type of suture material used in ultrasound-indicated cerclage but compared two types of 
braided sutures Mersilene or Ethibond to Mersilene tape96. As a result, the findings could 
not be included in the review as our research question was about comparing braided versus 
 
 
 
Case-cohort 
representative 
Selection 
of non- 
exposed 
control 
Assessment 
of exposure 
Outcome 
negative 
at start 
Comparability 
by design 
Comparability 
by analysis 
 Outcome 
assessment 
Duration 
or 
follow-
up 
Score 
   
Kindinger 
et al (2016) 
 * * * ** * * * 9 
   
Shoenfield 
et al (1999) 
* * * * * - * * 7 
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monofilament sutures. We still contacted the author to clarify whether they had any data on 
Monofilament suture use in ultrasound-indicated cerclages. The response was that they only 
used braided material such as Mersilene suture and Mersilene tape. The second author 
Abdelhak YE et al 95compared absorbable and non-absorbable sutures for cervical cerclage. 
Again we wanted to be specific whether sutures were braided or monofilament. There are 
some monofilament sutures like Nylon for example which are not absorbable. It was 
impossible to contact the author. So as a result only two studies were included into analysis. 
 
3.5.2 Quality assessment 
 
The Newcastle-Ottawa scales for Quality Assessment are presented in Table 5. The studies 
scored well on both scales. We were unable to create a funnel plot as only two studies were 
included in analysis so not possible to assess asymmetry. 
 
 
Figure 13 Meta-analysis of studies of type of suture material used for cervical 
cerclage 
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3.6 Discussion 
 
This meta-analysis included 2 studies including 691 women. It found that the type of suture 
material appears to influence the outcome of pregnancy with planned cervical cerclage. Use 
of multifilament braided sutures is associated with higher pregnancy loss. 
This review was strengthened by methodology. I used an extensive search strategy and 
used valid data synthesis methods. I used the Newcastle-Ottawa quality assessment scale 
for NRS studies. They scored well on the scale suggesting low risk of bias. Furthermore, no 
language restrictions were applied. The first study is relatively large (n=671) covering five 
big obstetrical units in UK with similar rates at each unit both for PTB and non-viable birth. 
They present data on both types of suture material and prove statistically that stich used in 
cerclage was the major variable which had impact on the risk of PTB independent of other 
variables such as maternal age, ethnicity, parity, and history of a previous PTB. They link 
poor outcome for pregnancies where braided sutures were used for cerclage with promotion 
of vaginal dysbiosis which leads to tissue inflammation and cervical remodeling due to that. 
The second study, even though small in size (n=20), gives very detailed information on 
suture material used in cerclage which was examined by special methods (SEM and X-ray 
diffraction analysis) and proves that monofilament material is associated with low rate of 
infection and had better pregnancy outcomes. 
 
 The review is limited by the number of included studies being only 2. Both studies have 
limitations. The first study by Kindinger et al is a retrospective review and there is no doubt 
that studies which do not involve randomisation are liable to potential bias. Even though it 
includes the prospective cohort, the outcomes are not presented. The second study is 
randomised but, as mentioned previously, authors do not specify type of randomisation. This 
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study was poorly designed not presenting important data on gestation at suture insertion or 
delivery, mode of delivery, demographic or any neonatal data.  
 
This systematic review addressed a research question, which could potentially save lives of 
more than 400 babies per year in UK dying as a result of mid-trimester loss, intrauterine 
infection or complications of prematurity. Moreover, reducing the risk of prematurity will 
reduce neonatal unit and hospital stay, the significant morbidity associated with early 
gestation and the associated long-term morbidity. This will have psychosocial benefits and 
significant cost saving for the NHS and the wider community.   
So in conclusion, this systematic review and meta-analysis demonstrates grade 2 evidence 
of a statistically significant difference in pregnancy loss associated with type of suture 
material used. It relies on evidence from very small NRS and studies which do not involve 
randomisation are potentially at higher risk of bias and overoptimistic results. So there is a 
need for proper RCT to address this issue. This study has commenced recently and is 
recruiting in the UK (C-STICH trial). The analysis of the data has resulted in a study requiring 
900 to be randomised and at the time of writing had recruited around 350. 
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4.1 Types of survey 
 
4.1.1 Background to survey methodologies 
 
A survey is a tool that can be used in qualitative research. It is a method of gathering 
standardised information from a sample or cohort of individuals. One of the uses of such 
surveys is to collect information in order to investigate whether current opinion, attitude or 
existing facts should be challenged121. Various methods can be employed to conduct a 
survey; examples of delivery mediums include postal, on-line, street, in-home, telephone, 
fax and interview. Each of these methods has advantages and disadvantages and has 
certain characteristics to other methods in common. The use of such surveys has a place in 
medicine as they can give the opportunity to healthcare professionals to collect systematic 
information on numerous factors such as the aetiology of the diseases, incidence of certain 
conditions, quality of life, etc. Despite this, according to some authors,  this tool is 
unfortunately not widely used by medics122. There are factors which will influence the 
clinician’s choice regarding the type of the survey to be carried out including required amount 
of data, sample size, time frames for completion of the project, accuracy of responses and 
avoidance of bias, cost of the survey and levels of  non-response123. 
4.1.1.2 Postal survey 
 
Postal surveys for example, involve the costs for postage, supply and individual’s time. 
Response time relies on the existing postal system. Data collection requires manpower. 
Postal surveys are widely used in educational enquiries124. Hoinville and Jowell in 1978 
identified some important factors that can influence the success of postal survey. Among 
them was using quality envelopes with the typed name of addressee. A second factor was 
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to use first class service with enclosed first class envelope for response125. The day of the 
week for mailing also seemed to be important. For example, if a postal survey was used for 
organisations then Monday and Tuesday were recommended. For personal surveys, 
Thursday was the best day for mailing out. They also recommended sending a follow up 
letter which was shown to maximise the response significantly. Follow up letters should re-
emphasise the importance of the survey and contain a further copy of the questionnaire with 
a first class envelope for return. The number of follow up letters obviously is limited but it 
can increase the response from 40% in a well-planned postal survey up to 70-80% with 
reminders used. Follow up letters should be sent 3 weeks after initial contact. If a second 
follow up is planned then the recommendation is a one-week gap. Follow up can be 
telephone as well as by post. Apart from follow up letters, the use of incentives is 
recommended in order to maximise response, especially when used with the first mailing. 
They should be selected accordingly and not perceived as a payment for efforts. Use of 
neutral incentives is recommended, for example stamps, or cheap pens that can be used to 
fill the questionnaire.  According to the authors, these initiatives can create a sense of 
obligation to complete the questionnaire in the postal survey participant.  Hoinville and 
Jowell developed a special flow chart for researchers who would wish to conduct a postal 
survey that can simplify the process. The flow chart presents different stages of the survey 
and the recommended sequence of it.125 
Whilst the response rate of a postal questionnaire is important, the investigators must also 
address the question of validity. Belson (1986) addressed the issue of the validity of the 
postal questionnaire by trying to identify whether respondents who completed survey 
answered questions accurately and whether those who failed to respond would have given 
the same answers as responders126. He offered a twelve step approach to be used in order 
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to check the accuracy of the postal survey, including familiarisation, probing, and 
challenging. He also suggested following up non-respondents by means of interviews and 
then comparing answers with respondents in order to address the issue of ‘volunteer bias’. 
Once data is collected it has to be cleaned and made suitable for analysis. For example, 
data is coded by hand for small surveys or with the help of computers if it consists of large 
data. Questionnaires are edited prior to coding. Editing eliminates errors. This process 
involves performing checks on completeness and accuracy i.e. that every question is both 
answered and answered accurately. Missing answers can be followed up by contacting 
respondents again or by checking other parts of the survey. With regards to accuracy, 
sometimes the wrong box can be ticked or the wrong code is applied which can lead to 
errors unless data is edited. It is also important that interviewers, those who are editing 
postal survey responses, are doing so uniformly following clear instructions. This uniformity 
leads to eradication of errors. Coding is important for subsequent computer analysis but not 
all data can be reduced for this purpose124. Sometimes coding can be included into the 
questionnaire itself, so answers are going to be pre-coded. When coding is done after a 
postal survey is completed and the questionnaire is answered, then it is called post-coding. 
Pre-coding can be used for close-ended questions, for example male/female, 
single/married/divorced. For open-ended questions, special coding frames are developed 
once a questionnaire is developed. For example, a random sample of questionnaires is 
taken and “a frequency tally of the range of responses as preliminary to coding 
classification”. Once a frame is developed the next step is to check validity. 
 
 
4.1.1.3 Fax survey 
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Another type of survey is a fax survey. Fax surveys are not popular as they involve the 
presence of machines on both ends (receiving and sending). On the other hand, telephone 
surveys/interviews are quite popular especially when the time to conduct a survey is limited. 
Telephone surveys can be limited to certain times of the day as people may not be able to 
answer the phone while they are at work, so calling time is limited to certain periods. In 
general, people may be reluctant to answer phone interview calls and would block certain 
numbers.  
4.1.1.5 In-person surveys 
In-person or face-to-face interviews tend to be expensive and quite often are conducted 
when more complex data needs to be collected127 and with a smaller proportion of the 
population (e.g. elections) or with a smaller sample size. They are widely used in qualitative 
research128 and classified according to the degree of structure and directness. The 
interviewer has a freedom to structure the questionnaire applicable to each conducted 
interview. Directness – is awareness of the survey participant of the survey’s purpose. In 
face-to-face interviews errors can be easily introduced first of all by misinterpretation of 
replies given by the participant to the interviewer. The attitudinal questions cause significant 
variance but they can’t be predicted easily129. Surprisingly the success of the in-person 
interviews doesn’t depend on interpersonal skills and personality of the interviewer130. 
Telephone interviews is a sub-type of in-person interview. They are cheaper to conduct, 
quick and effective method of survey especially when trained personnel is used. 
4.1.1.6 Web based survey 
With the advent of the internet, web based surveys have emerged which require access to 
the Internet on the sending and receiving end131. Web based surveys may be password 
protected and responses are collected and collated immediately into a pre-created 
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database131. Some studies have shown that several hundred responses can be generated 
within a short time frame using this method132. The advantage of this method is that 
information on response is available imminently, with specific information on how many 
questions were answered and how much time were spent on each of them. Web based 
surveys are usually not expensive to conduct as implementation is free and there is no cost 
for postage or paper. There is only a cost of designing the web page. Data analysis is simple 
as it is directly connected to analysing software132. The data is considered to be more “clean” 
as responses are entered directly by the participants thus excluding biases from survey 
conductors. Limitations include participants needing an email address and access to the 
Internet. 
Web-page based surveys usually cover large groups of users while email-based surveys 
cover small homogenous groups132. Advantages include participants being able to remain 
anonymous, if they wish, with the support of encryption technology, otherwise their names 
and email addresses may have to be collected automatically through email response. It has 
been shown that lack of anonymity does not decrease response rate133. Email based 
surveys allows the researcher to create a list of non-responders and re-request participation 
in the survey by sending reminders. That increases the overall response rate.  An advantage 
of email surveys over the postal survey is that any duplicate responses where the 
researchers sent numerous multiple questionnaires in an attempt to increase response rate 
can be eliminated134. Emails may contain survey questions, attachments or include a 
hyperlink for the website where questions would appear in a chronological order 
 5.1.2 Steps of successful survey 
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Overall the following factors are considered key to the success of any survey, irrespective 
of type: 
1. Addressing ethical issues. 
2. A well-designed/formulated questionnaire. 
3. Identification of target group and selection of sample size. 
4. Piloting the questionnaire. 
5. Data collection and analysis of pilot data with implementation of any required 
changes. 
Conducting surveys necessarily involves an element of intrusion into the subject completing 
the questionnaires life. Consequently there is potentially an ethical issue- of invasion of 
privacy.124 Survey respondents cannot be forced to complete the survey and the following 
rights apply: 1) right of informed consent; 2) right to withdraw from survey at any stage or 
answer only on certain questions; 3) guarantee of confidentiality and anonymity, unless 
expressly waived, which will normally reduce non-response rate but has been questioned 
by many qualitative researches135, 136; and 4) non-maleficence, meaning that participation in 
research/survey can harm them124. 
The second important issue is survey design which plays an important role in response rate. 
Questionnaires should be simple and short. For web and email surveys having a welcoming 
note, clarifying who you are and why you are doing the survey is beneficial. The quality of 
this message will encourage people to complete the survey. If options such as “Don’t want 
to answer”, “Don’t know”, “Not interested”, “Not applicable” are not included then some of 
the respondents may not even consider answering the question as they would feel forced 
into giving an answer. It is a good idea to leave space for comments at the end as one can 
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pick up interesting thoughts, views, and opinions which were not covered by survey 
questions but which may be important for the topic of the survey.  
 Sellitz and her group have published a guide to help researchers formulate and construct 
their questionnaires137. There is a staged sequence for planning a questionnaire. First of all, 
one needs to decide on the purpose it is going to serve, to identify the targeted population 
and to define the sample size. Moreover, it is important to identify issues to be addressed 
and to select the kinds of scales/measures/questions that are required. Piloting a 
questionnaire is always a good start before implementing the final version. 
The phrasing of the question and language used is important when developing a 
questionnaire. It is critical that surveyors and respondents have internal consistency and 
validity so that they assign the same meaning to the words used in the questionnaire128, for 
example when surveyors, medics and respondents are patients. Questionnaires can be 
structured, semi-structured and unstructured. They can contain closed and opened 
questions, multiple choice, rank ordering, ratio data questions, constant sum questions, 
rating scales and dichotomous questions. Irrespective of question type, collected data can 
be very accurate128 with open-ended questions being the most difficult for analysis. The 
advantage of open-ended questions is that respondents have a chance to disclose their own 
beliefs and views, which are normally linked together and explored as themes. The best 
reliability and reproducibility is with dichotomous questions (yes/no answer) especially when 
collecting information about the health matters138 but some authors139 think that they can 
lead to significant bias as usually people have a tendency to agree with the statement rather 
than disagree. The designer of the questionnaire has to decide not only on the type of 
questions to be used but also on scales of data to choose. 
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One of the most important parts of any survey is identification of the targeted population or 
“sample”. A decision on the sample size can be defined by various factors. For example, the 
statistical quality needed for findings, also on financial and human resources available to 
conduct the survey. The “sample” should be representative of the target audience and have 
characteristics of the total population127. One should be careful to avoid a biased sample as 
it may skew the end results. It is a well-known practice for large companies to create a 
separate research company to conduct their surveys to avoid potential bias as people may 
be more open to the third party140.  
Once a questionnaire is prepared and the targeted group identified piloting can take place. 
A pilot performs several important roles. It increases reliability, practicability and validity of 
the questionnaire141. For example, it is aimed to:  
1) Gain feedback on questions. 
 2) To test time taken to complete questionnaire. 
3) To identify irrelevant questions. 
4) To identify misunderstood or non-completed items. 
5) To test whether questionnaire is too long or too short. 
6) To get feedback on layout and numbering etc. 
There are two types of piloting. First one described above will concentrate on format of 
questionnaire and is not focused on data. It is distributed to limited number of respondents 
to gain their feedback. The second type will include a long list of questions which are 
eradicated through statistical analysis and feedback142. The data gained through the pilot 
will be analysed for reliability, collinearity, multiple regression and factor analysis. So through 
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this statistical analysis data will be removed and result in a shorter questionnaire of smaller 
proportion. The number of respondents in these circumstances has to be significant in order 
to generate reliable data for statistical analysis. 
The results of a survey can be presented in departmental meetings, emailed to stakeholders 
or published in the press, journals or books depending on reasons for the survey being 
conducted. 
4.2 Aims of the survey used in this thesis 
 
To conduct a survey to review practice amongst UK based obstetricians with regards to 
cervical cerclage procedure to understand current practice in the UK. A specific aim was to 
inform the researches about what emphasis the respondents attached to the suture material 
type used during surgery and its potential impact on outcomes and to inform on a 
subsequent trial design. 
4.3 Methods 
 
There are several advantages of internet-based survey which made this tool more attractive 
to me and as a result I have implemented it in order to perform my survey. As COTS was 
unfunded, cost played a major role. Internet-based survey significantly reduces the cost as 
there is no postage, printing or interview expenses involved. I also decided that this method 
will be the quickest as there is no time wasted to distribute, collect and analyse the data. All 
data will be entered into the web-based survey and processed automatically. 
Implementation of internet based surveys is often quicker due to the availability of survey 
templates. Internet-based surveys can also be distributed more quickly to a larger number 
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of participants compared with other survey methods. The participants can access and 
complete the survey in a time-frame to suit them in a self-chosen setting, for example at 
home or at work. The errors can be highlighted to the participant immediately thus giving 
the opportunity for correction resulting in less missing entries than in paper based surveys. 
 
Taking into considerations all mentioned advantages and based on the methodologies 
described above, I developed a pre-test questionnaire. This was piloted within a group of 
independent consultants at Birmingham Women’s Hospital before being modified and the 
final questionnaire being used to carry out a national survey. The aim of the pilot was to 
identify any areas for improvement such as wording, and length, as well as any 
unanticipated issues. A questionnaire was designed with the support of Birmingham Clinical 
Trials Unit (BCTU). 
Results of the pre-test questionnaire were analysed by members of the survey team and all 
applicable suggestions on modification of questions, their structure and sequence, were 
incorporated into the last version of the questionnaire. There were only few modifications 
such as adding one more primary outcome to question 9 (preterm birth rate less than 34 
weeks) and the sequence of questions were changed putting all questions about cerclage 
practice first followed by questions about the research proposal. 
The Royal College of Obstetricians and Gynaecologists maintain a list of UK based 
members and fellows who are Consultants obstetricians and gynaecologists who have 
agreed to participate in surveys. This list can be accessed through an application to the 
college giving details of the survey and reasons for wanting to circulate it (see request form 
attached - Appendix 2). Our application was successful with no modifications. There was 
no delay in response from the RCOG thus we could initiate our survey in timely manner. 
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Ideally we would have liked to be able to identify Consultants who no longer practices 
Obstetrics so as to be able to exclude them from the survey distribution and our denominator 
but this information was not on the RCOG register 121. We were able to exclude known 
Gynaecological Oncologists as they were unlikely to carry out obstetric procedures. 
Members and fellows were contacted via the email address listed on the RCOG database 
for them. A link to the survey with an introduction explaining the purpose of the survey was 
sent. Selected members and fellows were sent an invitation to complete an electronic survey 
via the Survey Monkey@ platform. This survey was conducted between February and April 
2012 with single reminder six weeks after the survey launch. There were several reasons 
why we decided to use Survey Monkey as a web based on-line survey tool. Firstly, BCTU 
had a significant experience in conducting survey through Survey Monkey platform and 
recommended it. It is free and therefore did not use any of the limited resources available 
for this thesis. It could be customised to our needs so that the programme not only collected 
the data but also performed data analysis and bias elimination. There were also significant 
ethical advantages as well in that responder IP (Internet Protocol) addresses are not 
collected, enabling respondents to remain anonymous. 
4.4 Results 
 
A total 1334 members and fellows were sent a link via email and 261 (19.5%) completed 
the survey. The denominator for each question was different depending on the number of 
respondents per each question 121.  
The main objectives of the survey were to identify current practice of Consultants and 
Obstetricians related to elective cervical cerclage. These included criteria for patient 
selection for elective cerclage; types of cerclage technique used; gestation at insertion; 
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number of cerclages performed per annum; and existence of local protocol or guideline to 
support their practice. The list of questions within the survey is shown in Table 7. 
Table 7. Survey questions 
Q1. Do you ever perform elective cerclage to prevent midterm pregnancy loss and preterm 
birth? 
 
1. No, I never perform elective cerclage as I do not see women at risk  
2. No, I never perform elective cerclage even though I see woman at risk 
3. Yes, I perform elective cerclage  
Q2. I perform cerclage on the basis of 
1. History of 2 or more midtrimester losses or preterm deliveries < 28 weeks 
2. Cervical sutures in previous pregnancies 
3. History of cervical surgery (e.g large cone excision) 
4. Risk of shortened cervix (<25 mm) 
5. Other 
 
Q3. Which approach do you predominantly use? 
            1.Transvaginal cerclage (McDonald) 
            2. High transvaginal cerclage (Shirodkar) 
 
Q4. Do you use Multifilament (e.g. Mersilene) or  Monofilament (e.g. Nylon) sutures for 
elective cervical cerclage? 
        1.Multifilament 
        2. Monofilament 
Q5. At what gestation do you usually/prefer to insert your elective cervical sutures? 
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        1.Pre-pregnancy 
        2.<11 weeks 
        3.12-16 weeks 
        4.>16 weeks 
        5. other (please specify) 
Q6. Do you have a guideline for insertion of cerclage in your department? 
        1.Yes 
        2. No 
Q7. How many elective cerclages do you estimate are done annually in your Unit? 
        1.0-20 
        2.20-40 
        3.40-60 
        4.>60 
Q8. Do you consider multifilament vs. monofilament an important research question? 
1. Yes 
2. No 
3. Not sure. Please send me information 
Q9. In your opinion, what is the outcome that will change your practice (rank the importance     
       from 1 (most)- 8 (least)? 
       1.Pregnancy loss before 24 weeks 
       2.Gestation at birth 
       3.Live birth rate 
       4.Preterm birth before 34 weeks 
       5.Take home baby rate 
Q10.Do you have any more comments 
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Table 8 Number of responses for each proposed primary outcome by rank. 
Answer 
options 
1 2 3 4 5 6 7 8 Total 
response 
count 
Pregnancy 
loss<24 
weeks 
66 29 15 18 29 6 1 11 175 
Gestation 
at delivery 
54 42 41 15 14 6 6 1 179 
Live birth 
rate 
21 43 27 35 19 13 9 7 174 
Preterm 
birth 
rate<34 
weeks 
27 36 45 30 21 7 3 3 172 
Take 
home 
baby rate 
66 31 24 18 9 9 7 8 172 
 
4.4.1 Current practice with planned cervical cerclage procedure 
 
The main objectives of the survey were to identify current practice of Consultants 
Obstetricians related to elective cervical cerclage. These included criteria for patient 
selection for elective cerclage; types of cerclage technique used; gestation at insertion; 
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number of cerclages performed per annum; and existence of local protocol or guideline to 
support their practice. 
Consultants were questioned whether they perform planned cervical cerclage in their routine 
obstetric practice in order to prevent SMTL or PTB and if they do is the inclusion criteria for 
cerclage based on RCOG No.60 guideline64 ( at the time the only guidance available for 
cerclage practice which is currently archived and replaced by NICE guideline on preterm 
labour and birth14). 
The majority of consultants (88%; n=227/258) performed a planned suture insertion in their 
routine practice. There were two reasons for not performing planned cerclage. First, 
obstetricians (5%; n=13/258) who would not offer cerclage as a treatment option for women 
with a history of PTB or SMTL. Second 7%(n=18/258) of obstetricians who would not 
perform cerclage as they were not involved in provision of care for this group of patients. 
Of the 202 respondents 77.2% (n=156) do less than 20 cerclage procedures, 19.3 %(39) 
perform between 20 and 40, 4 (2%) perform between 40 and 60 and only 3 (1.5%) perform 
more than 60 cerclages per annum respectively. 
Fifty of 200 respondents confirmed that they follow their hospital guideline on cervical 
cerclage. The majority, though, follow the RCOG recommendations for cerclage insertion. 
 Of the 202 consultants addressing the question on indications for cervical cerclage, 75.2% 
(n=152/202) insert cerclage if there is a history of two or more mid-trimester losses or 
preterm deliveries in the past. 72.8% (n=147/202) will consider cerclage if the patient had it 
in a previous pregnancy. 54.5% (n=110/202) will insert suture on the basis of shortening of 
the cervix on transvaginal scan<25 mm. 
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                                                          We were also interested in whether Consultants would 
offer cerclage to women with history of cervical 
sutures in previous pregnancies, as we were unsure 
as to how commonly this was still accepted practice, 
or any other personal criteria or hospital guideline. 
For each question of the survey, there was a possibility 
of leaving appropriate comments. Comments added in 
this section illustrate a lack of clear guidance as when       
to offer the cerclage: 
 
“We need to know if cervical surveillance should be done with after a single LLETZ as 
some patients insist”. 
“We insert very few elective sutures, most on women who have been referred to a 
specialist”. 
“Pre-term labour clinic due to identification of risk factors and are identified with signs of 
cervical shortening between 16-20 weeks. Truly elective cerclage tends to be performed 
on women who have had this in previous pregnancies and wish to have this repeated 
rather than monitor the cervix for signs of incompetence”. 
 
“Preterm reduction is by 46% and 40% respectively for progesterone treatment and 
cervical cerclage. There is no different on both treatments. With the surgical risk 
associated with cerclage more and more women now select progesterone treatment”. 
 
Figure 14. Availability of 
cerclage guideline in units 
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The questionnaire also included items on approach for 
cerclage, type of technique, vaginal (McDonald) or high 
vaginal (Shirodkar), and type of suture material used: 
Multifilament or Monofilament. Preferable gestation for 
suture insertion was one of other questions to address. 
The majority of respondents (88.7%; n=180/203) stated 
that they perform procedure between twelve and 
sixteen weeks of gestation. With regards to the 
technique used McDonald type of cerclage remains the 
most popular among obstetricians (83.4%; n=166/199). The Shirodkar technique is less 
popular with only (16.6% n=33/199) reported using it. 
Comments accompanying this question highlighted significant variation in cerclage 
approach and were as following: 
“The type of cerclage I put in depends on the length of the cervix at the time of insertion – 
if the cervix   is   a good length   then   McDonald, if   not then   I   dissect the    bladder off   
like   the beginning of a vaginal hysterectomy and go as high as I can”. 
“Technique is important to get high with the posterior bites so that weight of the pregnancy 
is not transmitted the suture”. 
“Performing a Shirodkar needs a wider tape or heavier duty Nylon, but how many people 
can perform a true Shirodkar any more, will this be a biased trial anyway …” 
“I see no place for a Shirodkar style suture. If there is not enough infra-vaginal cervix to 
insert   a   high   cervical   suture, then   an   abdominal   is   required, hence   the   bladder   
is   not touched”. 
“Choose my method of suture according to history and clinical findings”. 
Figure 15. Type of cerclage used 
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 4.4.2 Type of suture material used for cerclage is an important research question 
 
One of the most important questions for us was the type of suture material practitioners’ use 
for cerclage insertion and whether they think that the research question of impact of type of 
suture material on the outcome of cerclage is an important question to address. 
Most of the respondents routinely used multifilament braided sutures (86.6%; n=175/202) 
and (16.6%; n=33/202) monofilament.  
 
Almost half of the respondents (47%; n=94/201) 
considered the question of type of suture material used 
in cerclage comparing multifilament braided versus 
monofilament suture an important research question. A 
further (27.9%; n=56/201) were not sure and 
commented that would want to receive more 
information.  
 
 
The   following   quotes   illustrate   the   lack   of   information   about   Monofilament suture 
use in cerclage: 
 
“It is a traditional practice to use Mersilene in our unit.  PDS is used in our unit by some 
Obstetricians for rescue cerclage”. 
“I was not aware that McDonald can be done using monofilament sutures.  If McDonald is 
Figure 16. Type of suture 
material used for cerclage 
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done   using   monofilament   sutures, it   would   be   interesting   to   share   information   
with Obstetricians who have the widest experience”. 
“I have seen quite a number of the Nylon sutures cut through the tissues. Success is all to 
do with identifying the correct patients, placement of the sutures appropriately and timing 
of insertion”. 
“Mersilene seems to work fine and we don't have urogynae type complications due to short 
duration of use. Infection may be a factor and would make us change practice. SROM?” 
 
“I have come across several women with embedded monofilament material from previous 
cervical suture? PDS inserted abroad - I have never seen anyone use other than 
Mersilene in UK. I think there may be a concern that finer suture may cut through more 
easily”. 
 
4.4.3 Important primary outcome for future studies 
 
This survey was conducted as part of the justification to undertake COTS as a pilot/feasibility 
study. At this point in time our team of researchers were still equivocal about our primary 
outcome and hence the rationale for question 9. We therefore asked consultants to grade a 
list of possible outcomes on an 8-point scale where 1(most important) and 8 (least 
important)121. 
The sequence of rating was following:  
1) The most highly rated outcome-gestation at delivery. 
2) “Take home baby rate”. 
3) Pregnancy loss before 24 weeks of gestation. 
4) Preterm birth before 34 weeks of gestation. 
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 5) Live birth rate. 
Comments expressed by some consultants regarding primary outcome that can change 
practice included:  
“To me, the woman’s desire is to take a baby home. I feel that should govern our practice. 
Would be interested in your multi versus mono filament question! 
“Take home baby rate has been considered in some meta-analysis and has to be the most 
important factor- but also consider take well home baby rate. We sometimes manage to 
get a woman to 24 weeks but the baby has severe problems.” 
 
4.5 Discussion 
 
Obstetric practice for inserting cervical cerclage has remained unchallenged and 
controversial since the MRC study65. In the mid 90’s, the issue of cervical length was thought 
to be the key to improving selection to get better results from more selective cerclage. Until 
now, the issue of the impact of material type had not been addressed. This national survey 
was the first attempt to assess current practice with regards to elective cerclage procedure 
among UK consultant obstetricians and gynaecologists and to identify their views on our 
research hypothesis of whether the type of suture material can influence the outcome of 
planned cervical cerclage. The information obtained from the survey revealed major 
variations in some aspects of cervical cerclage practice, especially to the type of suture 
material used in cerclage. It also confirmed that many obstetricians are “ in equipoise with 
regards to the best suture material for cerclage”121 and that they were willing to participate 
in the study to address this question. The survey also identified a number of opinions and 
attitudes which were incorporated into research protocol for the COTS feasibility   study, 
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evaluating   the impact   of suture   material   on   the   outcome   of pregnancy   following   
cervical   cerclage comparing multifilament/braided sutures to non-braided monofilament. 
At this point in time there was no power calculation to know whether it was representative 
and the list was derived from self-selected consultants who were willing to be contacted. 
Our response rate was 19.5% and was comparable to the average response rate for RCOG 
conducted surveys, which is 20%. This therefore suggests our survey performed 
consistently when compared to other RCOG surveys. Most of the RCOG facilitated surveys 
faced the same issues as we did and that is probably the reason for the presumably low 
response rate143, 144. 
There are several factors, which could have influenced the response rate of any e-mail 
survey and ours in particular. The most common   problem   while conducting surveys is   to   
obtain   a   sample   frame   in   which   every   individual   in   the selected population has a 
known chance of being selected for participation126. We believe that had significant impact 
on the response rate of our survey. We were only able to contact those Obstetricians, who 
were happy for RCOG to disclose their contact details for survey purposes. Also, from 1334 
contacted some were practicing Gynaecology or practicing Obstetrics but not performing 
cerclage procedure, so were unable to participate in the survey. As a result, there was a 
decreased sample size, and we will have missed all the numerous Consultants who regularly 
perform cerclage and could have provided a valuable opinion on existing issue. So, we could 
have possibly obtained a higher response rate if we had avoided those issues. Having said 
that there is a good chance that the themes would have reached saturation by 200+. With 
this in mind we were reassured that the survey was well received and that the information 
obtained was representative and provided all the information to guide in the study design. 
So whilst we could have potentially obtained a higher response rate we believe that it was 
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unlikely that it would have given any greater granularity to the information obtained and we 
believe that the sample of consultants who participated, can still be considered 
representative of the larger group of obstetricians involved in provision of cerclage services. 
We could have also contacted BMFMS (British Maternal and Fetal Medicine Society) or 
preterm prevention clinics in tertiary hospitals to get the opinion of Consultants directly 
involved in cerclage provision but limitation in time didn’t make this possible. 
The results of this survey confirmed significant variation in practice121. We were able to 
establish that consultant Obstetricians were keen to participate in a research study looking 
at the type of suture material used for cerclage as most (75%) were still in equipoise 
regarding this matter. Considering there are no existing recommendations on the type of 
suture material to be used for cerclage, 86% of Mersilene use is extremely homogenous. 
On the other hand, some of the Obstetricians (according to comments left) were not aware 
about potential complications, associated with braided non-absorbable sutures such as 
erosion and infection, which are seen in other disciplines using multifilament 
meshes/tapes/sutures. As a consequence, there has been little to challenge this practice 
and explains why many still prefer to use Mersilene for its perceived strength. It is also easy 
to remove which is almost certainly due to its encapsulation103 and some of the practitioners 
are not aware and have never been taught that there is a possibility of using Monofilament 
sutures such as Nylon or Prolene for cervical cerclage. 
From the results of the survey, it is quite obvious that there is little consensus on the 
guidance as to when to offer cerclage and which category of patients would benefit. Most of 
the respondents loosely follow criteria suggested by RCOG guideline64 but, at the same 
time, there are practitioners who would offer cerclage based on their individual personal 
preferences.  
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The RCOG Guideline recommendation was to offer history-indicated cervical cerclage to 
women with a history of 3 or more mid-trimester losses and/or preterm deliveries <28 weeks; 
not to routinely offer it to women with a history of two or fewer mid-trimester losses or preterm 
births. The guideline also stated that cerclage can be offered in a planned manner to women 
with a shortened cervix on transvaginal ultrasound scan (less than 25 mm) who have a 
history of mid-trimester loss or preterm birth in the past and are less than 24 weeks of 
gestation. It did not suggest cerclage just only in case there is funnelling of the cervix without 
shortening. Women with an incidental finding of a short cervix on the scan should not be 
offered planned cerclage procedure, based on evidence from a randomised controlled trial 
of 302 women with singleton pregnancies and history of preterm birth or mid-trimester loss 
who were offered cervical length measurement versus expectant management. Insertion of 
cervical suture reduced the rates of both perinatal death and pre-viable birth but did not 
show an impact on the rate of preterm birth before 35 weeks of gestation; which was only 
significant if the cervical length was less than 15 mm91. A meta-analysis of 607 pregnancies 
confirmed that insertion of cerclage in women with short cervixes (less than 25 mm) and the 
same inclusion criteria led to reduction in delivery before 35 weeks of gestation75. 
The current guideline does not specify planned cervical cerclage as a procedure, instead it 
divides cerclage into 3 categories of history indicated, ultrasound indicated and rescue. In 
our survey we were only interested in the first two of these indications as such. That is why 
we defined it as planned cerclage (combining history indicated and ultrasound indicated) 
which are performed electively.  
Only a quarter of respondents had a hospital/departmental guideline to follow. The issue of 
patient selection will influence reported success rates of any surgical procedures. The 
significant variation in a patient’s selection and the indication for cerclage has been 
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attributed to variation in reported success rate for the procedure. According to our survey 
the majority of respondents had a variation in the RCOG guideline in that they would offer a 
planned cerclage to the patients who had a history of previous two or more mid-trimester 
losses or preterm deliveries and would offer that between 12 and 16 weeks of gestation 
(88.7%). Again there was significant variation from the RCOG guideline in women with 
singleton pregnancies and a history of previous cervical surgery such as large loop excision 
of the transformation zone, cone biopsy or any destructive procedures on the cervix. This 
stance is supported by recent evidence that large loop excision of the transformation zone 
is associated with an increased risk of spontaneous preterm birth145 . For those women it 
may be the only treatment option available especially now that the OPPTIMUM trial has 
confirmed that vaginal progesterone does not prevent preterm birth in women at risk of 
preterm delivery before 34 weeks of gestation60. 
 Our survey also suggested that on average most consultants perform less than 20 cerclage 
procedures per year. Taking into consideration the context of recent recommendations from 
NICE/RCOG regarding the annual workload for other surgical procedures, one could argue 
that in order to maintain the competence in the cerclage procedure, practitioners need to 
perform a certain number of them per year. For example, NICE recommends that in order 
to keep competence in urinary stress incontinence procedures, surgeons should perform at 
least 20 of them per year146. The RCOG on the other hand, recommends to do least 30 
invasive procedures annually in order to keep competence in amniocentesis147 .Given that 
there is evidence to confirm that, surgical competence is related to the outcome of the 
procedure, and that the benchmark is set for fetal medicine and urogynaecological 
procedures, there is an argument that there probably should be one set for cerclage as 
well121. 
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One of the most important outcomes of the survey was identification that our hypothesis as 
a research question was deemed important and of paramount importance for the UK 
obstetricians with three quarters of respondents supporting our research question121. They 
also identified “gestation at delivery” as the most important primary outcome for the future 
randomised controlled trial to test our hypothesis and address the question of what is the 
best type of suture material to be used for planned cervical cerclage, multifilament braided 
or monofilament material? 
 
Conclusion 
As part of the process of establishing a randomised controlled trial we decided to find out a 
general consensus from obstetric professional community on the topic of cervical cerclage 
and suture material used and to investigate whether our hypothesis should be challenged.  
This survey revealed a significant variation in current practice with regards to patient 
selection criteria, indications, technique and the number of procedures performed per year. 
Use of suture material for cerclage is largely homogenous with 86% using Mersilene, which 
is not evidence based. The majority of obstetricians were in equipoise with regards to the 
best suture material to be used for cerclage with 78% of participants considering our 
research question of great importance. 
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5.1 What is pilot/feasibility study 
 
Pilot feasibility project is a miniature of the main trial. The Concise Oxford Thesaurus gives 
a definition for the pilot study as a preliminary, exploratory test, trial or try out investigation, 
experiment148. Quite often pilot studies are viewed “vanguard trials” i.e. pre-studies. The 
pilot study tests the new idea or hypothesis and identifies whether the main trial is possible 
to run with established recruitment, randomisation, sometimes treatment and follow up. It 
often identifies the main aspects that needed for the design of the main trial. The main 
question to answer is: “Is this study be practically achievable?” and if yes, what are the 
important parameters which need to be taken into consideration? The design of the pilot 
study will very much resemble the design of the planned main trial. Sometimes the difference 
could be in time scales or fewer measurement points which are usually shorter, making pilot 
studies quicker and less expensive. Sometimes pilot studies collect the data which will not 
be a part of the main trial but does contribute significantly to the main trial design. For 
example, qualitative interviews with participants. Outcomes of those interviews can 
influence on recruitment procedures in the main trial.  
Pilot and feasibility studies quite often overlap but at the same time they each have their 
own characteristics. A pilot study, as mentioned before, is a small version of the main full-
scale trial. It is done to test feasibility of methods, procedures, techniques, sometimes 
interviews, survey or a particular research tool. Pilot studies usually test research protocol, 
its acceptability to patients and involved clinicians. There are several limitations of pilot 
studies. The most important is problems with the wrong conclusions/assumptions being 
drawn from the pilot data available. This can arise through problems with data contamination 
and funding issues 149. The other main issue is that pilot studies are quite often under 
reported which leads to potential replication of mistakes. Possibly journals are not in favour 
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of publishing data which doesn’t contain any significant statistical results. Well-designed and 
properly conducted pilot studies can provide information about the best research process 
and sometimes gives clues to the likely outcomes of subsequent studies. 
 A feasibility study is conducted to evaluate individual important components for the main 
trial. They are used to collect information to establish the feasibility of main study, its design 
and different processes. Some authors even developed guidance on maximising the effect 
of the qualitative component in feasibility trials for future RCTs150. Nevertheless, irrespective 
of differences, feasibility studies are often called pilot feasibility studies as the goals are 
almost the same. Most investigators and researchers would use those terms 
interchangeably. However, MRC and NIHR give exact distinctions between the two. NIHR, 
for example, sees pilot studies as a part of a main trial, sometimes a first phase of 
substantive study. 
 “a version of the main study that is run in miniature to test whether the components of the 
main study can all work together. It is focused on the processes of the main study, for 
example to ensure recruitment, randomisation, treatment, and follow-up assessments all run 
smoothly. It will therefore resemble the main study in many respects, including an 
assessment of the primary outcome151”. Whereas MRC considers both types of studies very 
similar and following the same goals and aims. 
 
5.2. Why do we need pilot studies? 
 
Some authors152, 153 suggest that there are four main reasons why pilot studies should be 
performed: 1) process- to identify feasibility of the steps needed to undertake in the main 
trial; 2) resources- identify financial difficulties which could be faced in the main trial and 
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calculate budget for the main-scale trial; 3) management- involves planning of the 
management of human resources involved in the study, necessity of managing data at 
involved centres etc; 4) scientific- which assesses the safety of the suggested methods of 
treatment and response to it, or any other intervention154. 
Because pilot/feasibility studies are the preliminary studies, they have to make sure that they 
follow certain goals and objectives that can convince the funding panels. First of all, they 
have to prove to funding bodies that data collection will be performed in the way to answer 
the question whether the main trial is feasible. Secondly, in both types of studies the main 
objective should be the estimation of recruitment rates. Even when researches are 
convinced about high recruitment rate, funders would want to see reassurance from the 
small scale pilot study. 
 
So, based on the results of three pieces of preliminary work; namely a retrospective dataset 
analysis, systematic review and a national survey I have justified a rationale for running a 
pilot/feasibility study to look at the outcome of pregnancies with planned cervical cerclage 
depending on the type of suture material used during the procedure to funding bodies. The 
rationale included several important points: 
1. PTB is one of the major challenges in Obstetrics and Neonatology globally 
 
2. A UK wide survey of Consultants obstetricians confirmed that there is variation in 
practice and they are not sure about the best type of suture to be used for the cerclage 
 
 
3. A significant number of clinicians are in equipoise as to which is the best suture 
material to use 
 
4. There is an emerging evidence about significant complications with braided non 
absorbable mesh-like suture material in ophthalmology and urogynaecology  
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5. Our meta-analysis suggested a significant risk reduction in pregnancy loss when 
using monofilament sutures 
 
 
6. It is possible that the actual effectiveness of this surgical procedure is reduced by the 
potential harm of the type of suture material that is commonly used for this procedure 
 
5.3 Research protocol 
 
 I have developed trial documents (Appendix 3,4,5) and initiated a pilot/feasibility study. 
The key trial document was a research protocol, which is presented in this chapter and has 
been published in Trials Journal155 in October 2014. Protocol writing usually precedes 
application for ethical approval and registration. COTS gained Ethical approval from 
Edgbaston Research Ethics Committee (COTS REC reference 12/WM/0141) (see letter of 
approval attached in Appendix 6) and was registered with the International Standard 
Research for Clinical Trials(ISRCTN17866773)  on 27 March 2013. Full text of the published 
protocol is online: http://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-15-
415. 
 Because of self-plagiarism regulations I haven’t included the whole protocol into this chapter 
as the wording of this work could not be modified. The research proposal for COTS was 
developed in a multidisciplinary manner and in conjunction with other disciplines and I 
acknowledge the contribution of these. The groups included obstetricians, midwives, 
statisticians, qualitative researchers, service users, the Birmingham Clinical Trial Unit 
(BCTU) team (see letter of support Appendix 7) and the Research and Development 
department at Birmingham Women's Hospital. External groups who contributed included the 
local BBC CLRN (Birmingham and Black Country Comprehensive Local Research Network) 
support and RCOG national preterm labour CSG (Clinical Support Group). The research 
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proposal was presented to both of these groups and feedback and comments were 
addressed and included into the final version. 
5.4.1 Format of research protocols 
 
The World Health Organisation (WHO) has a recommended format for developing research 
proposal/protocols. Firstly, each protocol should start from the title and registration date 
followed by general information which is the name of investigators who are conducting the 
research with their titles, responsibilities and contact details as well as the name of sponsor 
or funder of the study, if any. It is recommended that the title contains a summary of study 
design, treatment/intervention, comparators or placebo, population and indication, and 
sometimes the setting156. 
One person should be identified as Chief Investigator or Principal Investigator. It is usually 
the Senior researcher or MD/PhD student who has overall responsibility for the design and 
running of the study. If the research is clinically based, then the protocol should include the 
name and address of the institute, hospital or clinical laboratory where the research was 
conducted. Each protocol is assigned a version number, draft and date. This is important as 
then any changes can be tracked by Research and Development departments or Ethics 
Committee if the protocol needs to be modified in the future. The signature page will include 
signatures of all professionals involved in the study.  
The protocol should have well formulated reasons, based on the knowledge available, for 
conducting the particular research study. This includes the rationale or summary, followed 
by the goals/objectives and study design. In the COTS protocol I have described reasons 
for initiating the study based on information obtained from the literature search, systematic 
review and national survey and they are presented in the next chapter. I have formulated 
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the hypothesis and justified the reason for conducting a feasibility study. In the final 
published version, I have also included strengths and weakness of the study, as per 
requirements of Trials journal. The main weaknesses of the study were the inabilities to 
calculate sample size and estimate recruitment and attrition rate. However, the main 
strength was the understanding and support of our hypothesis by leading clinicians in O&G 
field in UK, RCOG Preterm birth specialty group and PPI (Patient and Public involvement) 
group. 
Any research protocol should include the flow chart which is a summary of the patient 
pathway through the study. My flowchart Fig 3. clearly states the population (participants) - 
women eligible for elective or ultrasound indicated cerclage between 12 to 21+6 weeks of 
gestation.  
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Figure 17. COTS study flow chart 
 
Based on inclusion criteria only eligible participants can be randomised to two groups which 
according to flow chart is under intervention section.  Subject selection is also important:  
1) Number of recruitment centres. 
 2) Source of participants for the study. 
 3) Inclusion and exclusion criteria.   
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With regards to recruitment, the process should be described in details including the method 
of recruitment (clinics, social media, adverts, university or hospital websites etc.), issues 
around consent (who will gain the consent and where, arrangements for non-English 
speakers, provision of patient information leaflet), payment to participants if any and, details 
of any tests required to assess eligibility to be included into the study.  
The intervention part of the protocol should give general information about intervention and 
control. In our case this included information about both types of suture material and detailed 
description of exactly how treatment (cerclage) is going to be performed and by whom. The 
intervention part should be followed or preceded by randomisation details. If a study is 
randomised, then researchers should specify type of randomisation: (e.g. simple, cluster, 
stratified, block, minimisation) and how many arms with details of whether the allocation is 
equal or unequal and, if the latter the allocation ratios. In blinded studies the allocation 
should be concealed (sealed envelopes, computerised etc.). The randomisation schedule 
should be described in detail including information on how it is going to happen, where, who 
is going to randomise, which randomisation pads are going to be used and out of hours 
rules. Researchers rely on the blinding procedures to improve the quality of their data and 
to avoid bias. In the case of COTS blinding was neither possible nor ethical. In view of logistic 
difficulties of ensuring blinding of participants and the fact that all the COTS outcomes were 
objective measures that were easily and independently retrieved from hospital records and 
hence unlikely that the lack of blinding was a cause of serious bias; we did not intend to 
attempt blinding participants or their assessors. Additionally, it was theoretically possible 
that the clinicians involved in the routine clinical care may require immediate access to this 
information. 
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The study design and type of trial should be clearly stated and justified.  COTS was a 
pilot/feasibility study as the preparation for the main trial. At the same time, it was a 
randomised controlled trial which we used to test recruitment, attrition rate and problems 
which can be faced with randomisation. 
The study provided the research team with a unique opportunity to identify and prepare for 
the challenges and uncertainties of evaluating the clinical interventions within a larger RCT. 
Conducting this study gave an opportunity to assess the acceptability of the study 
interventions to women with cervical incompetence; test the study protocol; and facilitate a 
formal sample-size calculation for the definitive study Cerclage Suture Type for an 
Insufficient Cervix and its effect on Health Outcomes (C-STICH). Ultimately, it enhanced the 
scientific rigour and value of the full-scale study.  
The methodology part of the protocol is of paramount importance. It should contain 
information on interventions involved, investigations to be carried out and procedures. 
Interventions should be described in detail, especially if any medicinal product or device is 
tested or used. In the case of COTS, I gave a full description of both types of suture material 
which is Mersilene tape and Nylon or Prolene sutures (depending on its availability in units 
involved in recruitment for COTS). 
In order to obtain the large number of patients necessary for the reliable evaluation of the 
best suture to use for cerclage, the trial needed the participation of several centres. To make 
this practicable, trial procedures needed to be simple, with minimal additional workload 
placed on participating clinicians, beyond that required to treat their patients. This was 
achieved by simple entry procedures (a single phone/fax call to the randomisation office), 
routine follow-up of patients (with few additional hospital visits or tests to be performed 
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above those done as part of standard care), minimising documentation and largely patient-
based evaluation of outcome.  
The pilot and feasibility randomised controlled trial (RCT) was conducted in three maternity 
centres in the UK in order to assess likely recruitment rates and acceptability across different 
sites.  
Safety considerations need to be clearly described in protocol explaining how safety of 
research participants will be protected. The protocol had a list of SAEs (Serious Adverse 
Events) and clearly specified as Serious adverse events believed to be due to cervical 
cerclage. This was reported on a Serious Adverse Event form and should have been faxed 
to the COTS study office on the number provided. SAEs still present at the end of the study 
must have been followed up at least until the final outcome is determined, even if it implies 
that the follow-up continues after the patient finishes the study treatment and, when 
appropriate, until the end of the planned period of follow-up. The BCTU was supposed to 
report all SAEs to the DMEC (Data Monitoring Committee) approximately 3-monthly, to the 
main REC annually, and to the Trial Steering Committee 6-monthly. Local Investigators were 
responsible for reporting SAEs to their host institution, according to local regulations, but 
they did not need to inform the main REC as this was done by the BCTU. 
Both suture materials tested in COTS are standard surgical sutures that are currently used 
for this procedure throughout the UK; hence, we were not anticipating any serious adverse 
events related to the surgery. However, Serious Adverse Events believed to be due to 
cervical cerclage were planned to be reported on a Serious Adverse Event (SAE) form. 
Project management section involved procedures on trial organisation and described 
responsibility of each member of team. The organisation of the trial was specified in order 
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to ensure the smooth running of COTS and to minimise the overall procedural workload. It 
was proposed that each centre should designate individuals who would be chiefly 
responsible for local coordination of clinical, pathological and administrative aspects. The 
COTS Trial Office, worked together with NCRN networks, and provided as much assistance 
as they could to local co-ordinators and investigators in obtaining Trust approval in each 
centre. The protocol should describe any potential ethical issues which can arise during 
study and cause ethical concern. I have clearly stated that conduct of the trial at each 
recruiting site including confidentiality and storage of all personal and research data would 
be in accordance with all applicable research governance regulatory requirements. All 
recruiting maternity units were required to sign a clinical trial agreement document detailing 
their commitment towards complying with the relevant laws, regulations, codes of practice 
and obligations to publication. Site specific and Research and Development approval was 
required for each recruiting unit. 
A Trial Steering Committee (TSC) was convened to provide overall supervision of the COTS 
study and adhered to the Medical Research Council (MRC) Guidelines for Good Clinical 
Practice. Any deviations from the clinical trial agreement were monitored by the TSC who 
would decide whether further action needs to be considered. An independent data 
monitoring ethics committee (DMEC) was convened for the COTS study by the sponsor and 
acted as an advisory committee to the TSC.  
The protocol should provide information on how data will be managed156. All personal 
information in COTS trial, received in paper format for the trial, was held securely and treated 
as strictly confidential according to BCTU policies. All staff involved in the COTS Trial 
(clinical, academic, BCTU) shared the same duty of care to prevent unauthorised disclosure 
of personal information. No data that could be used to identify an individual was so far 
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published. The data was entered on a secure computer database, either directly via the 
internet using secure socket layer encryption technology or indirectly from paper by the 
COTS Clinical Research Fellow (myself). Data was stored on a secure server at BCTU under 
the provisions of the Data Protection Act and/or applicable laws and regulations. 
The budget or financial section of the protocol should specify about the funding received. 
COTS was funded by Birmingham Women’s Hospital Urogynaecology Research Fund and 
organised by the University of Birmingham Clinical Trials Unit. The COTS trial didn’t offer 
any financial support to the collaborating hospitals for treatments. However, COTS did not 
involve any extra research costs for participating hospitals. The current standard of care is 
insertion of the cervical suture electively between 12 and 16 weeks of pregnancy. No 
additional follow-up visits or investigations were needed other than those that would 
normally be required for standard patient care. With regards to compatibility with other 
studies, COTS was the only study that was planning to explore different sutures used for 
cervical cerclage and associated outcomes. COTS was not an industry-sponsored trial, 
ABPI (Association of the British Pharmaceutical Industry) guidelines on indemnity did not 
apply and there were no special arrangements for compensation for any non-negligent harm 
suffered by patients as a result of participating in the study. The normal NHS indemnity 
liability arrangements for clinician initiated research applied (NHS Executive Health Service 
Guidelines HSG (96) 48, 8th November 1996). It was noted, however, that negligent liability 
related to the standard of care remained the responsibility of the hospital, whether or not a 
patient is part of a clinical trial, because of the duty of care that the hospital has for its 
patients. 
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The research protocol had information on the duration of the trial with a detailed month to 
month activity; expected outcomes; and results dissemination policy. CVs of all investigators 
were attached. 
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               Chapter 6- COTS study and results 
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6.1 Objectives for COTS study 
 
Main objectives of the COTS study: 
  Testing trial documents, especially assessing whether the research protocol is 
realistic 
 Identifying the number of eligible patients and ways to identify and approach them 
in order to maximise the recruitment 
 Gauge the acceptability of the research plan with the women participating in the 
study and the clinicians involved 
 Engage women in all aspects of the study and determine what outcomes are 
important from their perspective 
 Identifying willingness of participants to be randomised 
  Estimate likely attrition rates 
  Assessing the willingness of clinicians to recruit participants 
  Predicting the time needed to collect the data, problems with data clearing and 
analysis 
 Finalising the costing, including time involved, education and training, 
administration and organisational issues 
 Evaluating the service delivery and financial implications on the organisations 
involved in the research study 
  Providing the basic justification for applying for different grants and trying to 
convince funding bodies and other stakeholders that research team is sustainable 
and main study is feasible 
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 Establishing the likely success of the one type of suture over the other in cases of 
elective cervical cerclage. 
 
Feasibility studies are not usually designed to evaluate the outcome of interest and this was 
true in our case where we had already decided on the primary outcome. That is usually left 
to the main trial. The most important thing though that the sample for a pilot project should 
be representative of the target population of the main trial, obviously inclusion/exclusion 
criteria should be the same in the pilot and the main trial. Feasibility studies are used to 
inform on power calculations and sample sizes hence COTS didn’t have formal sample size 
calculation. The size of the pilot study will not allow reliable assessment of the effect of the 
intervention on clinical outcomes. In the pilot study, analyses will principally take the form of 
simple descriptive statistics of process outcomes, including eligibility and recruitment rates, 
and of live birth rate and secondary clinical outcomes, to aid designing of the main trial.  
Regression models, appropriate to the forms of data, will also be fitted, to allow adjustment 
for covariates. The systems and data collection tools will be developed and piloted.  These 
include the telephone randomisation system and the collection of the clinical data from both 
woman and baby prior to discharge from hospital.  
 
6.2 Preparatory work for the main trial 
 
COTS was undertaken into preparation for C-STICH. While running the pilot feasibility trial 
I have applied for several grants in order to secure funds for implementation of the main trial. 
The sequence of applications is following: Springboard Fellowship, Spark Clinical Research 
Fellowship scheme, Evelyn Trust, Wellbeing of Women research grant, Action Medical 
Research (AMR) and finally Research for Patient Benefit (RfPB) followed by Health 
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Technology Assessment (HTA). Each subsequent application provided us with valuable 
feedback and information which re-shaped the final definitive study. There were two main 
recommendations out of all applications, which had significant impact on strengthening the 
study. First one from AMR where the reviewers highlighted the clinical relevance, clarity and 
importance of the proposed research question, its potential impact on health services and 
social care and the clinical and academic rigour of the research team. However, it was 
suggested that the application would be strengthened by: 
1. A more thorough justification of study design: As a result, I have sought advice and input 
from the Birmingham Clinical Trials Unit (BCTU) and the West Midlands Research Design 
Service (RDS) regarding the study design. Following this consultation, it was deemed more 
suitable that we redesign COTS as a pilot/feasibility study to test procedures for recruitment 
& randomisation, estimate recruitment and attrition rates, test data collection procedures 
and confirm the level of resource required to ensure the successful delivery of a full study. 
2. Demonstrate the relevance of outcome measures amongst peers: With the help of BCTU 
and RCOG I have conducted a national survey of UK consultants who prioritised the 
importance of different clinical outcomes. Significantly, the primary outcome selected for 
COTS rated highest in the survey, hence supporting its clinical relevance. 
3.Reviewing current evidence: I have undertaken systematic review of randomised and non-
randomised studies to prove that the research question could not be answered by available 
primary research. 
The next major milestone in the history of the COTS application was feedback from RfPB 
(ref PB-PG-0212-27119) (Appendix 8, Appendix 9). The RfPB review panel highlighted the 
importance of the proposed research question. However, the panel suggested that our team 
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should aim for a full-scale study and recommended that we apply for NIHR Health 
Technology Assessment programme.   
The reviewers agreed that there was a clinical, scientific and ethical need for this full scale 
RCT to investigate the basic question of the influence of type of suture material on the 
outcome of cervical cerclage. They commended the appropriateness of the proposed 
research design for evaluating an intervention. They confirmed that work plan and project 
management plans were realistic and adequate. They recognised the expertise of the 
research team in, that, it included all appropriate clinical and methodological specialists and 
that members were very well coordinated. However, some reviewers raised a concern about 
the potential difficulty in engaging with other clinicians who might not wish to change their 
practice, which can potentially affect recruitment into the study. They thought that this may 
be problematic and could potentially pose difficulty in reaching recruitment targets. In view 
of this issue and because of moving to planning a full scale trial we have approached several 
clinicians who are national experts in the field of preterm labour and high risk obstetrics who 
has agreed to participate in the main trial. RfPB advised: 
1. To be more robust in terms of patient’s numbers as well changing study design 
2. Warned about problems with recruitment, as women may not wish to have “suture 
which is possibly associated with higher risk of infection” and the biased nature of the 
medical team also may make recruitment difficult. 
3. Advised on standardisation of surgical procedure for inserting the suture. 
4. PPI involvement should expand and PIL needs to have more lay language  
All that was taken into consideration especially PPI involvement and editing PIL. We have 
presented COTS to the Parents and Researchers Involvement in Maternity (PRIME) group 
(Appendix 10), a PPI group set up in collaboration with the University of Birmingham 
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CLAHRC (Collaboration for Leadership in Applied Health Research and Care) and has a 
geographical and socio-economically diverse spectrum of women with experience of 
Maternity Services use and their partners. The group supported COTS and agreed to 
provide the required lay representation on the study steering committee and promised to 
help with main trial. To alleviate anxiety of study participants after surgery, they suggested 
that when approaching women to participate, the possible risks associated with each suture 
material should be explained in general without specifying which material is associated with 
which risk. 
In preparation for HTA grant I attended numerous conferences and research meetings 
(Appendix 11) in order to familiarise obstetric and fetal medicine community with the 
objectives of COTS and get their support and recommendations. For example, COTS was 
presented at Birmingham and the Black Country Comprehensive Local Research Network 
BBC CLRN, Maternal Medicine and Preterm Birth CSG held at BMFMS, got endorsement 
from REACH (Reproductive and Child Health) group and RCOG pre-term CSG (Clinical 
Studies Group). I have also attended Surgery Research Writing Workshop organised by 
National Institute for health Research in London, in preparation for HTA application. Poster 
was presented at joint Annual Academic Meeting (RCOG) and Blair Bell Research 
Competition. 
6.3 Recruitment 
 
6.3.1 Ethical approval 
 
Initially a favourable ethical opinion was granted by NRES Committee West Midlands -
Edgbaston to the study with title: A pilot/feasibility RCT comparing 
monofilament(intervention) versus multifilament (control) suture material for elective cervical 
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cerclage in the management of suspected cervical incompetence, with reference number 
12/WM/0141 (Appendix 6) based on information described in application form, protocol and 
supporting documentation.  
6.3.2 Trial documents and PPI group 
 
The application form was filled through IRAS (Integrated Research Application System). It 
is an online system for applying for permissions and approvals for health and social 
care/community research in the UK. Supporting documentation, was developed before the 
application process commenced, included consent form, patient information sheet, letter to 
GP. The patient information leaflet was developed in conjunction with PPI (patient and public 
involvement) group. Their suggestions had a colossal impact on the way information was 
presented in the leaflet and as a result improved process of recruitment. The language and 
the content of the PIL became more accessible and appropriate. The women involved in PPI 
group had personal experience of midtrimester loss. 
PPI involvement (engagement, participation) in research projects are of paramount 
importance, especially in advice regarding study design, defining outcomes for the studies 
and developing research documentation, for example PIL etc. Members of public and 
patients may have personal experience of particular research topic and can provide 
researchers with their own perspective. Their knowledge and experience are usually quite 
different to researchers even though latter are experts in the field. A recent review by Staley 
(2009)157 found that public involvement was reported to be of particular value in clinical trials 
where it helped to improve trial design and ensured the use of relevant outcome measures. 
 In 2009, Professor Dame Sally Davies wrote157: “ No matter how complicated the research, 
or how brilliant is the researcher, patients and public always offer unique, invaluable insights. 
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Their advice when designing, implementing and evaluating research invariably makes 
studies more effective, more credible and often more cost efficient as well.” It is quite 
important to understand why do you want to involve public members in your research and 
identify who are those people. I have worked closely with a group of consumers and that 
has intrinsically changed all the researchers’ attitudes to the project and involvement itself. 
I wanted to involve women with previous experience of preterm birth and SMTL or those 
who had a cerclage procedure as a treatment for those conditions with positive or negative 
outcome. It is preferable to involve more than one person. The advantages include that you 
can involve them at different stages, give them a choice what they would want to be involved 
in, they can provide support for each other if needed, so that a range of opinions can be 
expressed and to be guaranteed involvement if one is ill or withdraws from the participation. 
As COTS was the pilot project, it was particularly important to actively involve users in design 
and management of the study. Two women with previous experience of SMTL and 
consequently cervical cerclage were recruited and agreed to be involved in the reviewing 
and provide feedback on trial documents including patient information leaflet and trial 
questionnaire. It made information clearer and more accessible as they made language and 
content of PIL more accessible for public. The primary outcome for the study was also 
selected in conjunction with patient group represented by patients with history of pregnancy 
losses in the past.  
A member of public was also able to advise on the Lay Summary (Appendix 12) for RfPB 
and HTA applications for the main trial. She was invited to sit on the Trial Steering 
Committee during the project lifetime and work in collaboration with research team from 
reviewing protocol documents to dissemination of the results, as evidence suggests that 
public involvement has had greatest impact when people have been involved through the 
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entire research project, rather than just at discrete stages.  Her participation in the project 
was within the frames of INVOLVE (2009) report recommendations157 on best practice for 
patient and public involvement. According to INVOLVE it is better to involve people at early 
stages of the study so they would have ownership of the research and feel part of it.  
6.3.3 Sands involvement 
 
Sands (Stillbirth and Neonatal death charity) was actively involved in COTS project. This 
organisation has national credibility and network to reach the broad geographical base of 
women and their partners affected by death of baby before, during or after birth. They 
provide support (emotional and informational help) to people through on-line forum, email, 
support groups or phone line. They have 3 core aims: 
 To support anyone affected by the death of a baby 
 To work in partnership with health professionals to improve the quality of care and 
services offered to bereaved families; and 
 To promote research and changes in practice that could help to reduce the loss of 
babies' lives 
The research and prevention manager of Sands gave valuable advice on Patient and Public 
Involvement. She was in charge of any future PPI involvement for the main trial through their 
organisation. 
After gaining Ethical approval for the project all necessary paperwork was forwarded to 
Research and Development departments of the three hospitals where the COTS study was 
implemented: main site- Birmingham Women’s Hospital NHS Foundation Trust, Birmingham 
City Hospital and Cambridge University Hospitals NHS Foundation Trust (Addenbrookes 
Hospital) (see letters of access attached Appendix 13). 
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6.3.4 Recruitment process 
 
The recruitment process involved screening of hospital notes in antenatal clinics on regular 
basis and identification of the patients who can be potentially eligible for elective cerclage 
procedure. In order not to miss any patients, theatre personnel were contacted and left with 
special note in booking office asking to contact the Research Fellow(myself) in case a 
cerclage procedure is booked. In this case contact details of the patient were collected and 
patient was telephoned or emailed (approved by Ethics Committee). 
If patients were identified in antenatal clinic, then after consultation with medical team I had 
a conversation with them about the study and provided them with participant’s information 
leaflet. The dates for cerclage procedures were always available in advance from theatre 
registry. Patients were contacted in the morning of the day of the procedure. Patients would 
then sign 3 copies of the consent form if they were happy to participate in the study. Multiple 
copies were in line with GCP so that a copy is given to the women, one is kept in the patient 
notes and the third in the local site file. Again in accordance with GCP the GP was notified 
about their participation in the study. All women approached were recorded on the screening 
log, available in the investigator site file.  
The recruitment process was started at Birmingham Women’s Hospital and then initiated at 
Addenbrookes Hospital and Birmingham City Hospital. Most of the patients were recruited 
at BWH (11/19), rest at Birmingham City Hospital and none at Addenbrookes. Problems with 
recruitment at other sites (different to BWH) were mainly due to the absence of a research 
fellow in the unit. As this was an unfunded pilot, recruitment was dependent on the 
availability of a research registrar, myself, for approaching, consenting and randomising 
women presenting to a number of obstetricians at each site. There were a few issues at 
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each site. For example, at BWH there wasn’t a preterm clinic so as a result patients were 
spread among various antenatal clinics. There were quite a significant number of 
laparoscopic cerclage procedures performed at BWH which had an impact on recruitment 
as well, however 100% consented at BWH all had procedure according to allocation. At City 
Hospital Birmingham there was a problem with availability of the interpreters to translate for 
recruitment process so as a result few patients were recruited but none was happy to be 
randomised. 
6.3.5 Randomisation 
 
Randomisation is the method used in clinical trials and other experiments in order to reduce 
bias. In clinical trials randomisations should allow every patient to have a balanced chance 
of receiving treatment or intervention (depending on the trial design treatment allocation).  
Randomisation is an important tool which allows to test efficacy of intervention or treatment. 
Randomisation requires generation of randomisation schedules. Through those schedules 
random numbers are obtained and given to each subject/intervention/treatment condition. 
Those random numbers can be generated by the computers or be taken from random 
number tables158. 
Birmingham Clinical Trials Unit provided randomisation services for the COTS trial. The 
BCTU is a partner in the Birmingham Surgical Trials Consortium, one of 5 centres 
designated by the Royal College of Surgeons as specialist surgical CTUs, and has 
conducted several trials in fetal medicine/ gynaecological surgery (including NIHR HTA trials 
PLUTO (07/01/44), OPT (06/404/84) and FEMME (08/53/22)). 
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The patients were randomised immediately just prior to the cervical cerclage procedure in 
order to minimise the number of withdrawals and protocol violations, but with enough time 
to ensure the obstetricians were able to prepare the sutures for the procedure. Patients were 
randomised to one of the arms: Monofilament suture Nylon or Prolene or 
Multifilament/braided Mersilene tape. I used telephone randomisation with a computer 
minimisation algorithm, with 1:1 allocation ratio. To reduce the potential for bias telephone 
randomization occurred immediately before surgery. Randomisation Forms were provided 
to investigators and used to collate the necessary information prior to randomisation. All 
questions on the Randomisation Form were answered before a trial number and allocation 
was given. Once all eligibility criteria were provided a trial number and treatment allocation 
was given. This process was followed by a confirmatory email sent to the randomising 
investigator and local Principal Investigator. In this case it was me as randomisation only 
happened at Birmingham Women’s Hospital. No randomisation took place at Birmingham 
City Hospital as none of the approached participants were happy to be randomised. 
It was impossible to blind the obstetrician performing the procedure to the type of suture 
material used. In view of the fact that all the COTS outcomes are objective measures which 
would be easily and independently retrieved from hospital records it was deemed unlikely 
that the lack of blinding would be a cause of significant bias. 
Both sutures used in COTS were standard surgical materials already in use in NHS hospitals 
so no additional cost was involved, and CE marked for this purpose. Mersilene® is a non-
absorbable, braided, sterile surgical suture composed of poly-ethylene terephthalate. 
Ethilon is a non-absorbable, monofilament, sterile surgical suture composed of the long-
chain aliphatic polymers Nylon 6 and Nylon 6,6.  Both sutures are marketed in the UK by 
Ethicon. For this pilot study cerclage insertion procedure wasn’t standardised. The technique 
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of suture insertion was at surgeon’s discretion. Removal of the suture didn’t require any 
specific guidance. So Consultants involved performed cerclage using McDonald or 
Shirodkar technique. All other aspects of postoperative management of patients for example 
tocolysis, progesterone, etc was again at discretion of the consultant in charge of care. At 
the time, there was no guideline on the management of women with cerclage in situ, so care 
was individualised depending on care-providing clinician.  
6.4 Data collection 
 
The data on all patients enrolled into the study was collected through the main hospital notes 
and separated into randomised and non-randomised groups, using data collection proforma 
(Appendix14). Those patients who were not randomised were still happy for the outcome 
of their pregnancy data to be collected. 
 
 
 
6.5 Outcomes 
As COTS was pilot/feasibility study data was not analysed and this only had a descriptive 
character. There was no difference noted in outcome of pregnancies depending on type of 
suture material used. 
I was planning to run the pilot/feasibility study in 3 centres with significant numbers of 
cerclage procedures performed. The objectives, as mentioned before, were few and they 
had to determine recruitment and retention rates, to assess women’s propensity to consent 
to participation, and to define presentations where randomisation was unfeasible, in order 
Number of women 
approached 
BWH=16    BCH=9 
Number of women eligible 
BWH=16 BCH=9 
Number of women declined 
BWH=8 BCH=9 
 
 
 
 
Number of women 
randomised 
BWH=8 BCH=0 
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to identify barriers to recruitment in the main trial. The aim was to target all potentially eligible 
women undergoing cervical cerclage, capturing reasons for ineligibility, refusal, and 
preferences for or against particular suture material or number of instances where the trial 
was never proposed to the patient. 
The major issue for all centres was absence of staff directly involved in recruitment and 
randomisation. As COTS was an unfunded pilot, recruitment was dependent on the 
availability of a research registrar (myself) for approaching, consenting and randomising 
women presenting to a number of obstetricians at each site.  The research fellow (myself) 
was based at Birmingham Women’s Hospital and as a result all patients who were finally 
randomised were recruited there. All had procedure according to allocation. Randomisation 
minimisation was used in order to minimize imbalance between treatments taking 
stratification factors into account.   
Nevertheless, it was still difficult to identify potential participants, as at the time of the pilot 
there was no preterm birth clinic at Birmingham Women’s Hospital and patients were 
referred to various antenatal clinics. When I moved to Birmingham City Hospital, recruitment 
at Birmingham Women’s Hospital continued with the support of a research Nurse who 
worked for the department of urogynaecology, covering a few research projects.  She was 
able to recruit 1 patient into the study. 
A unique issue for BWH was a significant number of laparoscopic cerclages were offered, 
accepted and performed for the suspected cervical incompetence. This also decreased the 
number of potential patients to be approached for COTS pilot. 
Recruitment at Birmingham City Hospital faced some major problems as well. The most 
important one was language barriers when communicating with potential participants. As 
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COTS was an unfunded study, we had no resources allocated for interpreting services. Thus 
where possible friends and relatives or members of staff were involved in translation. As a 
result, we faced significant misunderstanding regarding aims of the study, reasons to 
participate and benefits of participation for the patients themselves. A second issue was 
unwillingness of the Consultants involved in provision of cerclage service at Birmingham 
City Hospital to help with recruitment. They were directly involved in preterm birth prevention 
clinic service provision but on regular occasions, when I wasn’t present there due to rota 
commitments, missed the opportunity to provide information about participation in COTS 
study to potentially eligible patients. Also, most of them were not willing to place a suture as 
per randomisation allocation, in case one would take place, and warned me about it in 
advance, as they had their own preferences, not supported by any evidence but from 
experience with a preference for Mersilene tape over Monofilament sutures. As a result, I 
was unable to recruit successfully at BCH but this “failure” highlighted lots of important 
issues related to recruitment, which should be avoided or prevented in the main trial.  That 
was one of the main objectives of feasibility study. So overall 23 patients were recruited into 
COTS and only 8 of them were randomised.  
 
Table 9. Number of randomised patients 
Total              Randomised  Non-randomised but happy for data to be 
collected 
  23                      8                                14 
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As COTS was a pilot/feasibility study there was no formal sample size calculation but 
information from the preparatory work has enabled sample size calculation for the main trial.  
Based on our NRS meta-analysis, the pregnancy loss rate was 4% and 15% in the non-
braided versus the braided suture. In view of the small sample size and lack of randomisation 
it is highly likely that this effect size was exaggerated. Based on a retrospective data analysis 
of 49 cases of cerclage using non-braided sutures undertaken in 2 large maternity units, the 
pregnancy loss rate in this cohort was 5%. In contrast, in the cerclage group of RCTs 
included in the Cochrane review where braided sutures were routinely used, the cumulative 
pregnancy loss rate was 13%. Therefore, to demonstrate a more reserved reduction in this 
risk from 13 to 5% with the use of monofilament sutures we would require 147 women in 
each group (a total of 294 women) with 90% power (p=0.05). To allow for a 10% loss to 
follow-up rate we increased the total sample size to 330. Assuming a decline rate of 25%, 
we would need to approach 400 eligible women to achieve the required sample size.  
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                         Randomised    
No Ethnicity Parity Previous PTB/miscarriage Gestation at 
insertion 
Gestation at removal Swabs Type of 
suture 
Mode of 
delivery 
1 Asian (Indian) 2 SMTL at 20/40, followed by 2 
NVD with cerclage in pregnancy 
13/40 34+3/40 C/S Candida Monofila
ment 
C/S 
2 Asian(Pakista
ni) 
0 SMTL x 2 at 16/40 and 18/40 
Planned cerclage 
11+3/40 38+1/40 C/S Not 
done 
Multifila
ment 
C/S 
3 Black(African) 0 SMTL at 22/40 
Planned cerclage 
13+4/40 36+6/40 Not 
done 
Multifila
ment 
NVD 
4 Asian(Pakista
ni) 
2 SMTL at 20/40, followed by2 
NVD, both pregnancies had 
elective cerclage 
13+5/40 39+6/40 Candida Multifila
ment 
NVD 
5 White(English) 0 PTB at 26/40, neonatal death, 
TVS, short cervix on scan offered 
cerclage 
15/40 33+2/40 BV 
treated 
Monofila
ment 
NVD 
6 Black British 1 SMTL at 19/40, followed by NVD 
with planned cerclage at 13/40 
15+6/40 37+3/40 No 
growth 
Multifila
ment 
NVD 
7 Black 
(Carribean 
0 PTB at 28/40, TVS short cervix 15+2/40 NVD 31+1/40 Not 
done 
Monofila
ment 
NVD 
8 White(English) 0 SMTL at 16/40, TVS short cervix 15+1/40 38+1/40 Staph Monofila
ment 
 
 
Table 10 COTS: outcome data of randomised cohort 
 
Mean parity was 0.6 (range from 0-2). Mean maternal age at insertion was 31. Mean 
gestational age at insertion was 14.1 weeks (range from 11+3/40 -15+6/40) which is usually 
the common gestational age for planned cerclage insertion. Mean gestational age at 
removal was 36.1 weeks (range from 31+1/40 to 38+1/40). The majority of patients had 
previous SMTL and only two PTB in the past. Those with SMTL had planned cerclage and 
only one opted for cervical scanning and had ultrasound indicated cerclage. Three patients 
had a history of successful cerclage insertion in the previous pregnancies and as a result 
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opted for suture insertion in current pregnancy. The majority of patients in randomised cohort 
had normal vaginal delivery, two had Caesarean Section performed at 34+3/40 and 38+1/40 
both for fetal distress in labour. Unfortunately, swabs were not taken routinely before or after 
procedure and those taken randomly through the pregnancy presented in the table.  
So with regards to pregnancy outcomes depending on the type of suture material, 
monofilament suture was associated with more cases of preterm delivery before 34 weeks 
of gestation. But as sample was small though not considered statistically significant. 
 Neonatal outcome: 2 babies were admitted to NNU for short term and required respiratory 
support. All babies were discharged home in good condition. Long term follow-up wasn’t 
done as it wasn’t the objective of the study.  
The study was officially closed on 3rd of April 2014 when all data cleaning and analysis 
was performed (see letter of closure Appendix 15). 
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                     Chapter 7- Conclusion 
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This MD thesis reflects a substantial body of work. COTS was a pilot/feasibility study which 
provided necessary information to plan and confidently run the definitive trial into the role of 
cervical cerclage. This work provided the evidence that underpinned C-STICH. It is hoped 
that C-STICH will determine the clinical and cost effectiveness of the different types of suture 
material used for elective cervical cerclage and answer the question as to the major flaw in 
the MRC suture trial of the late 1980’s. The scientific question of use of different type of 
suture material for elective cerclage was never raised by obstetrical community before. This 
thesis provides the science behind the problems with braided/multifilament sutures in 
different surgical disciplines which allowed us to hypothesise that their use can have a 
detrimental impact on outcome of pregnancy. Braided sutures, instead of prolonging 
pregnancy, could cause infection, which may precipitate premature delivery or miscarriage. 
I have described the systematic approach of the COTS programme with its stepwise 
process, which initially involved retrospective data analysis and later was supported by the 
evidence from national survey and systematic review. Evidence from retrospective analysis 
and systematic review confirmed that the research question about the suitability of 
multifilament/braided sutures in cervical cerclage; and that they may be associated with poor 
obstetric outcome. The Systematic review confirmed that at the time of writing there were 
no RCTs addressing this issue. Our national survey proved that this scientific question is of 
significant interest to the Obstetrical community and that the practice with cerclage varies 
across the country. 
The COTS pilot/feasibility study met its main objectives: 
 
1. We tested all trial documents. As a result, the research protocol was modified as 
primary outcome for the main trial was strengthened from the live birth rate to 
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pregnancy loss as was advised by PPI group. The Patient information leaflet was 
also modified, taking into consideration recommendations from PPI and Sands. It 
was re-written in more lay language, avoiding term incompetence with regards to 
cervical weakness. Overall the research protocol seemed to be realistic and the 
consent form and letter to GP didn’t require any changes.  
2. We identified that a dedicated preterm birth clinic is the best setting to identify 
eligible patients and approach them. In units where preterm clinics do not exist the 
targeting of general antenatal clinics is complex and may be complicated. The 
process of recruitment and some of the eligible women can be potentially missed. 
This study helped in the establishment of a dedicated preterm birth clinic at 
Birmingham Women’s Hospital. 
3. We have created a PPI group as a part of COTS trial programme. Two women with 
previous experience of cervical suture placement were involved at the initial design 
stage. This process ensured that the women’s views were heard and the most 
important outcome to women was eventually chosen as the primary outcome. This 
has strengthened our belief that PPI involvement is of paramount importance for not 
just the main trial in this programme, but in all clinical research. 
4. The attrition rate was 0%, as after randomisation and suture insertion patients didn’t 
have any additional clinical intervention and any data about pregnancy and its 
outcome was collected routinely. There were no withdrawals from the study. 
5. We raised a concern about the potential difficulty in engaging clinicians who might 
not be open to the research question and not consider changing their practice, and 
thus possibly affect recruitment into the study. We addressed this by approaching 
several clinicians who are national experts in the field of preterm labour and high risk 
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obstetrics. We have had agreement from lead consultants and clinical academics in 
17 units in the UK (cumulative >85,000 deliveries per annum) who agreed to 
participate in COTS once funding was secured for the main study (C-STICH). 
6. The PPI group were instrumental in advising on the willingness of participants to be 
randomised. They identified possible risk factors associated with each suture type 
should be explained in general terms without paying specific attention to which 
material is associated with each particular risk. 
7. As a result, we were able to furnish the basic justification for applying to different 
funding bodies and were successful in securing funds for the main trial. 
COTS has proved to be a successful pilot/feasibility study as it has not only met all objectives 
but also secured funds for the main trial (successful £1.2 million NHR HTA grant) which at 
the time of writing has recruited 899 women. COTS was successful for several reasons.  
From the start the study was endorsed by RCOG preterm labour Clinical Study Group. Also 
we have received the support from REACH (Reproductive Health and Childbirth) the local 
specialty group CLRN network for recruitment into the study. The research protocol for this 
study was developed in conjunction with obstetricians, midwives, statisticians, a qualitative 
researcher, service users, the Birmingham Clinical Trial Unit (BCTU) team and the Research 
and Development department at Birmingham Women's Hospital. Their experience and 
expertise made COTS achieve its main goal and secure the grant. 
On a personal note I have faced many challenges during the journey of this thesis. COTS 
was funded by soft monies which had a significant implication on study flow.  At the time of 
the pilot there was no preterm birth clinic at Birmingham Women’s Hospital and patients 
were referred to various antenatal clinics, there were few laparoscopic cerclage procedures 
being performed, as one consultant had an interest in this. Recruitment was initially wholly 
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dependent on the availability of a research registrar as this was not a portfolio study, 
interpreters were not available to translate and many others which are described in chapter 
6. Despite these obstacles COTS was completed and lead to main trial.  
If I were to have the time again COTS again I would have done things in the same order. 
COTS was a learning curve for me. I acquired research skills, understood fully process of 
gaining ethical approval, developing study documents, applying for different funding bodies, 
producing scientific papers and participating in research meetings and discussions where 
your idea is challenged and questioned. I also gained lots of friends and collaborators which 
the most valuable asset. I have developed both as a clinician and researcher during my time 
undertaking this work. 
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Part A. Demographic data 
Hospital number ________________   Initials _______   
Ethnicity  
White                   Black/Black British   Asian/Asian British       Mixed 
British                  Caribbean                Indian                 Mixed White/Black Caribbean     
Irish                       African                    Pakistani            Mixed White/Black African  
White other           Black other             Bangladeshi           Mixed White/Asian  
                                                            Asian other             Mixed Other  
 Chinese or Other Ethnic Group 
Chinese  
Any other             Not given  
Part B. Clinical data 
Past obstetrical history _________________________________________________ 
                                     _________________________________________________ 
                                     _________________________________________________ 
 
Gestation at insertion   _____/40    Suture type    Mersilene                    
Gestation at removal     _____/40                          Nylon/Prolene  
                                                        Technique     McDonald  
                                                                              Shirodkar  
Surgeon Consultant                        Outcome        NVD 
               SST                                                        C/S 
               SpR                                                        Other 
 
Gestation at delivery   ______/40 
 
Swabs taken  
                      Yes              Growth ________________ 
                      No 
Appendix 1- data collection proforma for retrospective 
analysis 
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Appendix 2 – Request form for RCOG, page 1 
 
134 
 
Appendix 2- Request form for RCOG, page 2 
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Doctor 
Practice 
Street 
City 
Postcode 
Date 
Dear Dr <gp name> 
Name......................................................D.o.B....................NHS No...................................... 
Your patient, named above, has been recommended an elective cervical cerclage as a part of her 
pregnancy care and as such suitable for entry to COTS, a pilot/feasibility study looking at pregnancy 
outcome after elective cervical cerclage in relation to type of suture material used, comparing 
monofilament (intervention) versus multifilament (control) suture material. 
 
Birmingham Women’s Hospital is acting as trial sponsor. The University of Birmingham Clinical Trials 
Unit are acting as coordinating centre. The study is funded principally by the Birmingham Women’s 
Hospital. 
Your patient has been informed about the COTS trial, has consented to take part and has been 
randomly allocated to either Multifilament or Monofilament group. 
If you have any queries about the patient's management, please feel free to contact me. If you 
require any further information about the COTS trial, it can be obtained from the COTS trial office 
(see address below). Please file this letter in the patient’s notes. I would appreciate being notified if 
they are no longer one of your patients. 
Yours sincerely 
 
Name 
Position 
 
 
 
Appendix 3- Trial documents, notification letter to 
GP
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                                                                                                         Version 1.0 Date 23/04/2012
 
Consent Form 
Title of Project:  COTS study (Cerclage Outcome by Type of Suture) 
Name of the Researcher: Dr Fidan Israfilbayli                                          Please initial 
1. I confirm I have read and understood the information  
leaflet dated 07/06/2012 Version 2 for the above study.  
I have had the opportunity to consider the information,  
ask questions and have had these answered satisfactory. 
 
2. I understand that my participation is voluntary and I am 
free to withdraw at any time without giving any reason. 
 
3. I agree to be randomised and be contacted in the future  
for an interview about trial recruitment 
 
4. I give permission to inform my GP about my participation 
 in study. 
 
Please choose from the following options remaining: 
 
a) I agree to be randomised but don’t want to be contacted 
 in the future for an interview about trial recruitment 
 
b) I don’t want to be randomised but agree for researches to 
retrieve information from my medical notes  
 
5. I understand that relevant sections of my medical notes and data  
collected during the study, may be looked at by individuals from  
Birmingham Women’s Hospital NHS Trust, where it is relevant to 
my taking part in this research. I give permission for these individuals 
to have access to my records. 
 
__________________  __________________ _________________  
Name of patient    Date    Signature 
 
Name of person taking consent          Date    Signature
Appendix 4- Trial documents, Consent form 
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PARTICIPANT INFORMATION SHEET 
 
COTS study (Cerclage Outcome by Type of Suture) 
 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take 
time to read the following information carefully. Talk to others about the study if you wish. 
 
Why have I been invited? 
 
You have been approached because your Obstetrician has recommended a cervical stitch as a 
part of your pregnancy care and as such suitable for this study. Cervical stitches are usually 
offered to women who have had pregnancy problems in the past usually preterm delivery or 
late miscarriage which may suggest a weak cervix. A Cervical stitch may reduce this risk by 
helping to keep cervix closed for longer allowing a baby more time to develop and reduce the 
risks associated with premature delivery. 
 
What is the purpose of the study? 
Cervical cerclage has been used for cervical incompetence for over 50 years. Currently there 
are two types of stitches commonly used for maintaining the cervix closed. Mersilene is a 
type of stitch that has been traditionally used in cases of a suspected weak cervix because it’s 
braided materials to offer better strength. In contrast Nylon is a single filament suture 
proposed to have the benefit of reducing infections which is considered to be one of the 
important reasons for preterm labour and probably stitch failure. Currently there is no 
evidence to support either of the sutures. We aim to find out whether the type of stitch makes 
any difference in preventing the preterm birth. To our knowledge COTS is the first study to 
address this issue. 
 
Do I have to take part? 
No. It is up to you to decide. The researcher will telephone you in the next few days to ask if 
you wish to take part. You will have an opportunity to go through this information leaflet 
with the researcher.  
 
What will happen to me if I take part? 
 
You will be asked to sign the consent form to show that you have agreed to take part. You are 
free to withdraw (change your mind) at any time, without a reason. This would not affect the 
care you receive. 
 
There are 4 choices of participation in this study: 
 
1. You would like to take part in the study(be randomized) and be contacted in the future 
for an interview about recruitment into the trial 
 
Appendix 5- Trial documents, Patient information 
leaflet, page 1 
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2. You would like to be randomized but don’t want to be contacted in the future for an 
interview about recruitment into the trial 
3. You don’t want to be randomized, but you are happy for  us to subsequently retrieve 
data from your notes 
 
4.  You don’t want to be randomized and you don’t want us to review your notes 
 
If you agree to participate you will be randomly (by chance) allocated to one of the two 
groups (Monofilament or Multifilament suture). The allocation to one of the groups will not 
affect the type of anaesthetic, the timing of the suture or future pregnancy management. We 
will then retrieve all other data from your notes. On agreement you will receive a further 
phone call to discuss your feelings about the study, as we also wish to investigate women’s 
feelings and thoughts about being involved in research. 
The stitch will be inserted under either general (you will be asleep) or regional anaesthetic 
(injection in the back) and you will therefore be awake. It is usually performed between the 
twelfth and sixteenth week of pregnancy.The length of time you will be in hospital depends 
on your consultant's instructions. However, you will probably go home the day after your 
operation. The cervical stitch is removed by a doctor at 37-38 weeks of pregnancy or when 
labour starts. The removal of the stitch does not usually require an anaesthetic. If you are 
going to have Elective Caesarean Section, then suture removal will be delayed until that time. 
When the stitch is removed, we will ask your permission to retain it for microbiological 
investigations. 
 
 
 
What will happen if I chose not to take part? 
 
Nothing. If you decide not to take part, please inform the researcher when (s)he telephones 
you. The researcher will not contact you again. This will not affect any care you receive from 
Birmingham Women’s Hospital. If you were not in the study your doctor will still insert the 
stitch round the cervix using one of the above sutures dependent on their usual practise as 
part of your antenatal care. 
 
What are the risks of taking part? 
 
There are no additional risks associated with taking part in this research. The risks of any 
cerclage are described below. 
 
Both stitches are commonly used and have theoretical advantage in preventing preterm labour 
or midtrimester loss. Inserting cervical stitch is a relatively common procedure. However, 
there are always risks to any surgical procedure. The uncommon risks (occur in 1 out of 100-
1000) include bleeding, infection and pain. It is usual to experience some period like tummy 
pain afterwards. We can give you some painkillers if necessary. You may also have some 
slight vaginal bleeding. This should stop within a few days. If you have increased vaginal 
discharge and your doctor worried about the infection, you may have vaginal swab taken. If 
there is evidence of infection you may be prescribed antibiotics. 
There is no evidence that abstinence from sex following cerclage insertion has any impact on 
preterm delivery. It is also not routinely recommended to get a complete bed rest after the 
procedure. 
 
Appendix 5- Trial documents, Patient information 
leaflet, page 2 
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In a very small percentage of cases there is a technical difficulty with the procedure, so it may 
result in miscarriage or rupture of membranes. This is not, as far as we are aware, related to 
the suture material. The risk of premature delivery of the baby remains throughout the 
pregnancy (but this is the reason for the stitch). 
 
What are the possible benefits of taking part? 
 
There are no direct benefits to participants. The information we get from this study will help 
us to identify which suture is best to be used for the cerclage(stitch round the cervix) and is 
the best for prolongation of pregnancy. 
 
Are there any contraindications to cerclage insertion? 
 
Yes, there are. Cerclage cannot be performed if you have a signs of infection in your womb 
or in membranes round the baby, if you have continuing vaginal bleeding. 
 
If you have any concerns? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researcher Dr F Israfilbayli on . If you wish to complain about the study, you 
can contact our Patient Information and Advice Centre (PAIC) on 0121 6272747. 
 
Will my taking part in the study be kept confidential? 
 
Yes. We will follow ethical and legal practice and all information about you and your baby 
during the course of the research will be kept strictly confidential. 
 
What will happen to the results of the research study? 
 
We aim to publish the results in scientific journals. You will not be identified in any report or 
publication. Your personal details are not shared with anyone outside Birmingham Women’s 
Hospital. A copy of the results will be offered to you at the end of the study. 
 
Who is organising and funding the research?  
Study is funded by Birmingham Women’s Hospital. 
 
Who has reviewed the study? 
Edgbaston Research Ethics Committee, Birmingham Clinical Trials Unit and Birmingham 
Women’s Hospital Research and Development Committee have reviewed the study. 
 
Contact for further information 
If you want to know more about the study or there are any issues you would like to clarify 
please contact: Fidan Israfilbayli  
 
Thank you for taking time to read this leaflet. We hope that you will be willing to help us 
with this study. 
Appendix 5- Trial documents, Patient information 
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COTS study addresses a research question, which could potentially save the lives of 
more than 400 babies per year in the UK alone. These babies would otherwise die 
because of severe prematurity or early pregnancy loss. Undoubtedly, the improved 
outcome will have significant psychosocial benefits and health resource implications. 
Laxity of the neck of the womb (cervix) is one of the main causes of premature birth 
and early pregnancy loss for which a suture around the cervix (cerclage) has been 
used for many years. It is estimated that 6700 women will have a cerclage in the UK / 
year with varying success rates. Braided sutures have been traditionally used because 
they are deemed to be strong and easy to remove. However, braided non-dissolvable 
sutures have been consistently associated with increased risk of infection in most 
surgical procedures and are no longer used in eye and pelvic surgery for that reason. 
Infection is a major contributing factor to cerclage failure. Hence, some surgeons 
prefer to use monofilament non-braided sutures in cerclage. However, there is 
perceived concern about the degree of cervical support such sutures offer. We 
conducted a national survey of UK-based consultants Obstetricians & Gynaecologists 
which demonstrated that the majority of doctors were uncertain which is the best 
suture material for their patients. Therefore, COTS pilot study will provide the 
necessary information to confidently inform the need for a large national multi-centre 
study.  
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